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ABSTRACT
The lepidopteran adipokinetic hormone M-AKH was synthesized 
using solid-phase Fmoc chemistry in order to investigate its 
activity in the tobacco hornworm, Manduca sexta. An M-AKH specific 
radioimmunoassay was developed and used in conjunction with HPLC to 
determine the M-AKH content of neural tissues from larval and adult 
Manduca. M-AKH appears to be located almost exclusively within the 
corpora cardiaca (CC), with adult moths possessing ten times more 
peptide (21 pmol/CC) than fifth instar larvae (2.2 pmol/CC). A 
small amount of immunoreactive material was detected in brain 
extracts, but HPLC analysis of the extracts suggested that this 
material is not M-AKH.
Synthetic M-AKH activated fat body glycogen phosphorylase when 
injected into larvae and mobilized lipid from the fat body when 
injected into adult moths. A comparison of the dose-response curve 
for phosphorylase activation by M-AKH with previously published 
data on the activity of CC extracts suggests that M-AKH is 
identical to the larval glycogen phosphorylase activating hormone 
(GPAH), which is released during starvation. This conclusion is 
supported by the radioimmunoassay of,haemolymph from starved and 
fed larvae which indicated the release of M-AKH during the first 
hour without food. It was not possible to account for all of the 
adipokinetic activity of CC extracts in terms of their M-AKH 
content. The possible presence of an additional adipokinetic factor 
in the adult CC is discussed.
The pharmacology of the adipokinetic response in adult Manduca 
was investigated using synthetic AKH/RPCH family peptides. Most of 
the peptides tested lacked adipokinetic activity at a dose of 
50 pmol/insect, however AKH-I from locusts, HTF-II from stick 
insect and M-II from a cockroach were partial agonists eliciting an 
increase in haemolymph lipid equivalent to 55-68% of the maximal 
response to M-AKH. A competition assay in which AKH/RPCH peptides 
were co-injected with M-AKH indicated that the partial agonists 
were binding to the same receptor population as the native hormone. 
The sequence requirements of the Manduca AKH receptor are 
discussed.
The means whereby M-AKH is inactivated was investigated. A 
neutral metalloendopeptidase with M-AKH degrading activity was 
partially purified from larval Manduca haemolymph. The 
physiological role of this enzyme is unclear but it seems unlikely 
that it has a primary role in M-AKH inactivation.
CHAPTER 1. METABOLIC REGULATION IN INSECTS
INTRODUCTION
Animal tissues depend upon the maintenance of a supply of 
metabolic fuel in order to survive and function. Carbohydrates, 
lipids and proteins may be stored following bouts of feeding and 
mobilized subsequently in response to an increased demand for 
metabolic energy. Metabolic regulation is important for all 
organisms with a varied intake of fuel substances (few animals feed 
all the time and the nutritional content of each meal probably 
varies). The demand for energy also varies depending on the level 
of physical activity or the disease status of the animal, and other 
physiological conditions such as starvation or reproductive status 
have a profound effect on the metabolic needs of the animal.
METABOLIC FUELS IN INSECTS
I shall introduce the subject of insect metabolism with 
particular reference to flight. A more comprehensive review of the 
biochemistry of insect flight metabolism has been provided by 
Beenakkers et al. (1985c) whilst carbohydrate and lipid metabolism 
in insects have been reviewed by Friedman (1985) and Downer (1985), 
respectively.
Insect flight is probably the most metabolically demanding 
activity known in any animal. The energy requirement of an insect 
at the onset of flight may be up to one hundred times greater than 
that of the resting insect (Friedman, 1985). Flightless insects, 
including larval stages, may also experience large variations in
metabolic demand, particularly during periods of starvation which 
occur normally during the development of many insects (e.g. 
Lepidoptera). Both flight and starvation challenge the maintenance 
of a regulated supply of metabolic fuel to the insect's tissues.
There is no universal metabolic fuel for flight in all insects. 
The importance of carbohydrate was demonstrated by Jongbloed and 
Wiersma (1934) who reported that the respiratory quotient (RQ) of 
flying honeybees (Apis mellifera) was equal to 1, indicating 
carbohydrate metabolism. Wyatt and Kalf (1957) demonstrated the 
importance of the disaccharide trehalose when they correlated wing 
beat frequency with haemolymph trehalose concentration in the 
blowfly, Phormia regina. In locusts carbohydrate is utilized during 
the early stages of flight but lipid is the major fuel during 
sustained flight (Krogh and Weis-Fogh, 1951; Beenakkers, 1973). An 
early report of the RQ of several lepidopteran species during rest 
and flight suggested virtually exclusive metabolism of lipids 
(Zebe, 1953) however it is now known that many Lepidoptera utilize 
both carbohydrates and lipids (Beenakkers et al. , 1985c). Amino 
acids (in particular proline) are a third form of fuel used in 
insects. The concentration of proline in flight muscle falls during 
flight in the tsetse fly, Glossina morsitans indicating its 
utilization (Bursell, 1963). The role of proline in flight 
metabolism appears to be very variable between insect species and 
it will not be discussed further here.
Carbohydrate-utilizing insects possess large stores of glycogen 
in their flight muscles, haemolymph and in the fat body (the insect 
equivalent of the mammalian liver and adipose tissue). Flight,
especially its initiation, demands a very high rate of carbohydrate 
utilization. The glycogen content of locust flight muscle was shown 
to be reduced by 64% during the first 10s of flight (Rowan and 
Newsholme, 1979). The open circulatory system of insects results in 
the slow distribution of fuel substrates, so a high haemolymph 
concentration of fuel is required during flight. Since trehalose 
yields twice as much energy per osmotically active particle as 
glucose, it is more suitable as the primary carbohydrate fuel in 
insects. Trehalose is synthesised in the fat body following the 
degradation of stored glycogen (Friedman, 1985).
Lipids are stored in the form of triacylglycerols in the fat 
body. During flight the lipolysis of triacylglycerols yields 
monoacylglycerols which are then reacylated to form the specific 
diacylglycerols that are secreted (Beenakkers et al. , 1985a). These 
diacylglycerols are transported to the flight muscle in association 
with haemolymph lipoproteins which are recycled following 
dissociation at the flight muscle (Wheeler and Goldsworthy, 1985a).
In general, predominantly carbohydrate-utilizing insects such 
as the honeybee are less capable of sustained flight than pre­
dominantly lipid-utilizing insects such as the locust. This is 
probably due to the greater efficiency of lipid metabolism and 
storage (Beenakkers et al., 1985c).
PEPTIDE HORMONES AND INSECT METABOLISM 
Vertebrate-like Peptides
By analogy with vertebrate systems in which insulin and 
glucagon have major roles in metabolic regulation, insect
metabolism might be expected to be influenced by peptide hormones.
A number of studies have reported the presence of insulin-like and 
glucagon-like substances in insects and have compared their 
biological activities with those of injected insulin or glucagon 
(see Kramer, 1985). Insulin-like and glucagon-like substances were 
identified in the corpora cardiaca-corpora allata (CC-CA) complex 
of the tobacco hornworm, Manduca sexta by radioimmunoassay (Tager 
et al., 1976). An insulin-like peptide was subsequently purified 
from the haemolymph of Manduca larvae and shown to have a similar 
amino acid composition to vertebrate insulin (Kramer et al., 1982). 
Insulin-like immunoreactivity was also found in the median neuro­
secretory cells from the brain of the blowfly, Calliphora 
vomitoria. This material displayed insulin-like bioactivity when 
assayed on isolated rat adipocytes or in the blowfly (Duve et al., 
1979). The midgut of the locust, Locusta migratoria contains an 
insulin-like peptide which displays hypoglycaemic activity 
(Gourdoux et al., 1985). This peptide also stimulates glucose 
catabolism as does insulin when injected into Locusta (BenKhay 
et al., 1987).
A hypoglycaemic factor has been reported in the CC of the 
cockroach, Periplaneta americana which can induce hypolipaemia in 
the locust but not in the cockroach. Bovine insulin mimicked these 
effects (Barrett and Loughton, 1987). The cockroach factor may be 
similar to a hypolipaemic factor isolated from the storage lobe of 
the locust CC by Orchard and Loughton (1980). Despite this evidence 
for vertebrate-like peptides with insulin- and glucagon-like 
bioactivities in a number of insect species the principal hormonal
regulators of insect flight metabolism are peptides which are quite 
distinct from insulin or glucagon.
Adipokinetic Hormones in Insects
Steele (1961) reported the existence of a hypertrehalosaemic 
factor in the CC of Periplaneta which could be responsible for the 
regulation of carbohydrate metabolism in that insect. Some years 
later two independent reports identified a hyperlipaemic factor in 
locust CC (Mayer and Candy, 1969; Beenakkers, 1969). It was 
proposed that this 'adipokinetic hormone' (AKH) controlled lipid 
metabolism during sustained flight in the locust. Goldsworthy 
et al. (1972) demonstrated the release of AKH from intrinsic cells 
within the glandular lobe of the CC and Hekimi and O'Shea (1987) 
have recently demonstrated the synthesis of AKH within these cells. 
Locust AKH was sequenced from the CC of two species Locusta 
migratoria and Schistocerca gregaria by Stone et al. (1976). It was 
found to be a decapeptide with a similar sequence to that of the 
red pigment concentrating hormone (RPCH) previously sequenced from 
the eye stalk glands of two prawn species (Fernlund and Josefsson, 
1972). The sequences of these two peptides are:
AKH pGlu-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH^
RPCH pGlu-Leu-Asn-Phe-Ser-Pro-Gly-TrpNH^
The manner in which AKH regulates locust flight metabolism has 
been studied extensively (for a recent review see Orchard, 1987). 
The nature of the humoral influences on AKH release remain unclear,
although they may be related to changes in haemolymph carbohydrate 
levels. Beenakkers et al. (1985a) reported the suppression of 
secretomotor cells, which can trigger AKH release, by the resting 
level of trehalose. They suggested that in the early stages of 
flight when the haemolymph trehalose level falls, the secretomotor 
cells become active triggering AKH release. Orchard and Loughton 
(1981) demonstrated the neural regulation of AKH release by the 
nervi corporis cardiaci (NCCI and NCCII) which extend to the CC 
from the brain. Electrical stimulation of NCCII evoked AKH release 
from the CC whereas stimulation of NCCI did not. However stimu­
lation of NCCI potentiated the release of AKH caused by NCCII 
stimulation. Octopamine, which is present in the CC and NCCII, is 
thought to act as a transmitter between NCCII and the CC, causing a 
change in the intracellular level of cyclic AMP (cAMP) which leads 
to AKH release (Pannabecker and Orchard, 1986).
The action of AKH on the fat body was thought to be mediated by 
cAMP. CC extracts have been shown to increase the levels of fat 
body cAMP, dibutyryl cAMP mimicked CC activity and cAMP levels were 
shown to be elevated after flight (G&de and Holwerda, 1976).
However Goldsworthy et al. (1986) found that the increase in fat 
body cAMP following the injection of purified AKH was less 
pronounced than might have been expected, raising the possibility 
that the increase in cAMP may not be directly related to lipid 
mobilization. A recent study using synthetic AKH demonstrated the 
failure of AKH to increase fat body cAMP at doses that produced a 
maximal elevation of haemolymph lipid. Actually, AKH appeared to 
inactivate membrane-associated adenylate cyclase, the enzyme which
catalyses cAMP formation from ATP (Loughton, 1988). Consequently 
the role of cAMP in mediating the action of AKH on the fat body 
remains uncertain.
Diacylglycerol released from the fat body in response to the 
action of AKH, associates reversibly with a haemolymph lipoprotein 
(known as high density lipophorin, HDLp or Ayellow, Ay) and smaller 
proteins (known as apoLp-III or C -proteins) to form a new lipo-
Li
protein complex (known as low density lipophorin, LDLp or A+) 
(Wheeler and Goldsworthy, 1985a; Shapiro et al., 1988). This 
complex is transported to the flight muscle where a membrane-bound 
lipoprotein lipase hydrolyses the diacylglycerol to free fatty 
acids which can enter the muscle cell to be metabolised. The 
activity of the lipase is greatly enhanced when the substrate is 
the low density lipophorin (A+) compared with its activity against 
the resting state lipophorin (Ay), so AKH appears to regulate lipid 
utilization at the flight muscle indirectly by increasing the level 
of the preferred substrate (Wheeler and Goldsworthy, 1985b). A 
direct effect of AKH on lipid utilization has also been proposed. 
The oxidation of diacylglycerol by flight muscle was shown to be 
enhanced by AKH and it was suggested that this may be due to the 
stimulation of carnitine acyl transferase which catalyses the 
transportation of fatty acyl coenzyme A across the inner 
mitochondrial membrane to the site of oxidation (Robinson and 
Goldsworthy, 1977).
The majority of the carbohydrate utilized during the early 
stages of locust flight can be obtained from the haemolymph pool. 
However fat body glycogen phosphorylase (which catalyses
carbohydrate mobilization) is activated early on in flight and AKH 
has been shown to be responsible for this activation (Van Marrewijk 
et al., 1986). During sustained flight AKH may maintain carbo­
hydrate metabolism at a reduced rate whilst lipid metabolism is 
stimulated.
AKH has been shown to cause the non-specific inhibition of 
protein synthesis by locust fat body (Carlisle and Loughton, 1979, 
1986). Initially this phenomenon was thought to be an adaptation 
for maximizing the efficiency of flight metabolism, however this 
explanation has since been rejected and the true physiological 
explanation remains unknown (Orchard, 1987).
A number of peptides displaying structural and functional 
similarities to AKH have been isolated and sequenced from different 
insect species (Table 1.1). The original locust AKH is now known as 
AKH-I following the discovery of two additional peptides in Locusta 
and Schistocerca (Carlsen et al., 1979) AKH-II occurs in smaller 
quantities than AKH-I and is generally less potent. The 
physiological role of AKH-II remains uncertain. A number of other 
insect species have also been shown to possess two AKH/RPCH family 
peptides. M-I and M-II from Periplaneta are responsible for the 
hypertrehalosaemic effect originally observed by Steele (1961) and 
they also display cardioactivity (Scarborough et al., 1984) and 
myoactivity on a skeletal muscle preparation (O'Shea £t al., 1984). 
The physiological significance of these activities is unknown. HTH 
appears to be primarily a carbohydrate mobilizing hormone in its 
cockroach hosts (Gade and Rinehart, 1986; Hayes et al., 1986) 
whereas G-AKH is thought to be primarily a lipid mobilizing hormone
in crickets (GSde and Rinehart, 1987b). The physiological roles of 
HTF-II, Rol, II, DCC-I, DCC-II and H-AKH-II in their native insects 
are not known. In the following chapters I shall describe my work 
on the adipokinetic hormone, M-AKH from the tobacco hornworm, 
Manduca sexta.
Legend to Table 1.1. Sequences determined by: a) Stone et al., 1976; b) Fernlund and Josefsson, 
1972; c) and d) Siegert et al., 1985; e) and f) Witten et al., 1984; g) Ziegler et al., 1985 and 
Jaffe et al. , 1986; h) G&de and Rinehart, 1987a; i) Gade and Rinehart, 1986 and Hayes et al., 
1986; j) and k) Gade et al., 1988; k) Gade and Rinehart, 1987b; 1) and m) hypothetical sequences 
based on Jaffe et al., 1988a; n) Jaffe et al., 1988b.
Table 1.1. The AKH/RPCH family of peptides.
Peptide Sequence Source
a) AKH-I pGlu-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH^ Locusta, Schistocerca
b) RPCH pGlu-Leu-Asn-Phe-Ser-Pro-Gly-TrpNH^ Pandalus, Leander
c) AKH-II(S) pGlu-Leu-Asn-Phe-Ser-Thr-Gly-TrpNH^ Schistocerca
d) AKH-II(L) pGlu-Leu-Asn-Phe-Ser-Ala-Gly-TrpNH^ Locusta
e) M-I pGlu-Val-Asn-Phe-Ser-Pro-Asn-TrpNH^ Periplaneta
f) M-II pGlu-Leu-Thr-Phe-Thr-Pro-Asn-TrpNH2 Periplaneta
g) M-AKH/H-AKH-I pGlu-Leu-Thr-Phe-Thr-Ser-Ser-Trp-GlyNH^ Manduca, Heliothis
h) HTF-II pGlu-Leu-Thr-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH2 Carausius
i) HTH pGlu-Val-Asn-Phe-Ser-Pro-Gly-Trp-Gly-ThrNH2 Nauphoeta, Blaberus
j) Rol pGlu-Val-Asn-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH2 Romalea
k) RoII/G-AKH pGlu-Val-Asn-Phe-Ser-Thr-Gly-TrpNH2 Romalea, Gryllus
1) DCC-I pGlu-Leu-Thr-Phe-Thr-Pro-Gly-TrpNH2 Tabanidae
m) DCC-II pGlu-Leu-Thr-Phe-Thr-Pro-Gly-Trp-Gly-TyrNH2 Tabanidae
n) H-AKH-II pGlu-Leu-Thr-Phe-Ser-Ser-Gly-Trp-Gly-AsnNH2 Heliothis
o
CHAPTER 2. PREPARATION OF SYNTHETIC MANDUCA AKH
INTRODUCTION
The synthesis of biologically active peptides using solid-phase 
and solution methods has facilitated the performance of detailed 
physiological and biochemical studies by providing pure peptide 
in amounts far greater than could be readily obtained by purifi­
cation from the native tissue. This is particularly true for 
the study of insect peptides such as the members of the AKH/RPCH 
family, where the tissue source is very small and may contain 
only a few picomoles (pmol.) of peptide. The sequencing of 
AKH-I required 3,000 corpora cardiaca (CC) pairs from Locusta 
and Schistocerca (Stone et al., 1976) and despite improvements 
in the sensitivity of sequencing techniques 300 CC pairs were 
needed for the sequencing of AKH-II from Schistocerca and 
Locusta (Gade et al., 1986).
Synthetic AKH-I was prepared soon after the sequence had 
been elucidated and truncated analogues were synthesized in 
order to investigate the sequence requirements of the locust 
AKH receptor (Stone et al., 1978). AKH-I analogues containing 
modified amino acid residues were synthesized by a combination 
of solid-phase and solution techniques (Hardy and Sheppard,
1983) and a specifically tritiated analogue of AKH-I has been 
synthesized and reported to possess full adipokinetic activity 
in locusts (Muramoto et al., 1984).
An adipokinetic factor was demonstrated in the corpora 
cardiaca (CC) of the tobacco hawkmoth, Manduca sexta a decade
ago (Beenakkers et al. , 1978). This factor elevated haemolymph 
lipid levels when injected into adult Manduca but not when injected 
into Locusta. It was suggested that the Manduca adipokinetic factor 
was different to that isolated from locusts.
Ziegler et al. (1984) isolated the Manduca adipokinetic hormone 
from acetic acid extracts of adult Manduca CC by reversed-phase 
HPLC (.RP-HPLC). Amino acid analysis revealed a nonapeptide sharing 
seven amino acid residues with locust AKH-I. The sequence of 
Manduca adipokinetic hormone (M-AKH) was determined by Ziegler 
et al. (1985) using fast atom bombardment tandem mass spectrometry. 
M-AKH is an uncharged peptide with.an amino-terminal blocked by 
a pyroglutamate residue and a carboxy terminal blocked by glycine 
amide. The sequence of M-AKH is:
pGlu-Leu-Thr-Phe-Thr-Ser-Ser-Trp-GlyNH^
In order to investigate the biological activities of this 
hormone in Manduca I have synthesized the native peptide and two 
analogues [Tyr^]M-AKH and [IodoPhe^]M-AKH, using the fluorenyl- 
methoxycarbonyl (Fmoc) chemistry developed recently to permit 
solid-phase peptide synthesis on a polyamide resin (Dryland and 
Sheppard, 1986). The synthesis, purification, structural confirm­
ation and bioassay of M-AKH and the two analogues will be described.
MATERIALS AND METHODS 
The Pepsynthesiser System
The syntheses were performed by a Pepsynthesiser II (Cambridge 
Research Biochemicals (CRB), Cambridge, U.K.) in the School of
Chemistry, University of Bath. Fmoc amino acid derivatives were 
obtained from C.R.B. The Fmoc group protects the amino terminal 
(N-terminal) of the derivative during the coupling procedure.
The carboxy terminal (C-terminal), which couples to the resin or 
the previously coupled residue, is activated in the form of a 
pentafluorophenyl ester (Pfp) which reacts more readily than the 
Fmoc free acid. The Pfp esters of threonine and serine exist as 
pastes rather than crystalline solids so 3,4-Dihydro-3-hydroxy- 
4-oxo-l,2,3-benzotriazin (Dhbt) esters of these amino acids were 
used instead. L-Pyroglutamic acid pentachlorophenyl ester (from 
Sigma) was used for the coupling of the N-terminal pyroglutamate 
residue. Those residues which possessed a labile side chain (Ser,
Thr, Tyr) were protected by a tertiary butyl ester (tBu) during 
the assembly. A comprehensive description of the use of Fmoc 
derivatives in peptide synthesis is provided by Atherton and Sheppard 
(1987).
The Pepsyn KB resin upon which the peptides were assembled 
consists of a polyamide gel held in the pores of an inert Kieselguhr 
matrix. The resin is derivatised with a linking agent (4-hydroxy- 
methylbenzoic acid) to facilitate the synthesis of peptides which 
are blocked by an amide or hydrazide group at the C-terminal. The 
resin loading specified by the manufacturer defines the quantity 
of peptide which can be synthesized on a given weight of resin 
and is expressed in milliequivalents of peptide per gramme of 
resin, where 1 meq equals 1 mmol of peptide. The resin loading 
for the batch of Pepsyn KB used here was 0.12 meq/g, therefore 
in order to synthesize 100 mg (0.1 meq) of crude M-AKH, 0.83 g
14.
of resin was required (since 0.1 meq 0.12 meq/g = 0.83 g).
All the solvents used during the syntheses were obtained from 
the Aldrich Chemical Co., Gillingham, U.K. and the dimethylformamide 
(DMF) was redistilled prior to use. A four-fold excess of reagent 
was used throughout the assemblies which were monitored by the 
u.v. absorbance of the circulating solvent at 314 nm using a Cecil 
CE1220 spectrophotometer. The procedure used to synthesize 100 mg 
of crude M-AKH (theoretical yield) will be described. The 
analogues were synthesized by the same method, using two reaction 
columns connected in series. These columns were disconnected from 
each other for the coupling of the residues which are distinctive 
to each peptide. The Pepsynthesiser II system is illustrated 
diagrammatically in Fig. 2.1.
Preparation and Coupling of the First Derivative
The peptides were assembled from the C-terminal with the initial 
residue being coupled to the resin using an Fmoc symmetical anhydride 
of the amino acid. The anhydride was prepared freshly from 0.8 meq 
of the Fmoc free acid which when mixed with dicyclohexylcarbodiimide 
(DCCI) yielded 0.4 meq of the anhydride. For the synthesis of M-AKH, 
238 mg of FmocGlyOH was dissolved in a mimimal volume of dichloro- 
methane (DCM) with the addition of a few drops of dimethylformamide 
(DMF) in a round bottomed flask. The solution was stirred while 
76 mg (0.38 meq) of DCCI, also dissolved in a minimal volume of 
DCM, was added. After 10-15 min of stirring the symmetrical anhydride 
had precipitated together with dicyclohexylurea (DCU). Rotary 
evaporation was used to remove the DCM and the anhydride was
redissolved in DMF. The DCU remained insoluble in DMF and was retained 
by the sinter when the anhydride was added to the reaction column.
The coupling of the anhydride to the resin was catalysed by 
12 mg of 4-dimethylaminopyridine (DMAP), dissolved in a minimal 
volume of DMF, which was loaded into the reaction column immediately 
before the FmocGly anhydride. The reaction mixture was recirculated 
through the column for 2 h to ensure complete coverage of the resin 
with the first residue. The extent to which thejresin had been covered 
by the first residue was assessed by the qualitative Kaiser test 
(see below). The initial coupling for the synthesis of the analogues 
was assessed by the quantitative Kaiser test and by amino acid 
analysis. During the synthesis of [IodoPhe^]M-AKH the FmocIodoPhe 
anhydride was prepared from the FmocIodoPhe free acid (a gift from 
CRB) and coupled in the manner described for the Gly anhydride.
Fmoc Deprotection and Subsequent Couplings
Once the glycine residue had been coupled to the resin the 
Fmoc group was removed from the N-terminal to permit the coupling 
of the next residue. This deprotection step was achieved by a 
10 min recirculation of 20% piperidine in DMF through the reaction 
column. The system was then washed through with DMF to remove all 
the piperidine prior to the second coupling. For the coupling,
59 mg of the catalyst 1-hydroxybenzotriazole (HOBT) was added 
to the sample tube followed by 238 mg (0.4 meq) of FmocTrpOPfp 
dissolved in a minimal volume of DMF. The reaction mixture was 
pumped through the column until the u.v. absorbance of the eluate 
(at 314 nm) began to rise, at which point the flow was switched
to the recirculate mode for 40 min. A few granules of resin were 
then removed for the qualitative Kaiser test and recirculation 
was resumed while the test was performed. When the test indicated 
complete coverage by the second residue, Fmoc deprotection was 
repeated and the next residue was coupled. If the Kaiser test
indicated incomplete coupling a second Kaiser test was performed
which always indicated completion of the reaction.
Qualitative and Quantitative Kaiser Tests
The completion of each coupling step was assessed by the 
qualitative Kaiser test (Kaiser et al., 1970). For the synthesis 
of the analogues, the initial anhydride coupling was assessed 
quantitatively by the modified Kaiser test (Sarin et al., 1981).
For the qualitative test a few granules of resin were removed 
from the reaction column, placed in a small, sintered, glass column 
and washed sequentially in DMF, DCM, diethyl ether, dried under 
nitrogen and placed in a small pyrex test-tube. One drop of each 
of the following solutions was added to the granules:- 
Kaiser 1. Ninhydrin (500.mg) in ethanol (10 ml)
Kaiser 2. Phenol (40 g) in ethanol (10 ml)
Kaiser 3. 10 mM KCN (2 ml) in pyridine (98 ml)
The tube was heated in an oven at 100°C for 5 min and the 
colouration of the granules was then inspected. A blue colouration 
indicated incomplete coupling, white or straw-coloured granules 
indicated complete coupling.
For the quantitative test a small sample of resin was removed 
from the reaction column and placed in a sintered glass tube. The 
resin was deprotected by 4 column volumes of 20% piperidine in 
DMF and dried by washes with DMF, DCM, ether and finally under 
nitrogen. Approximately 6 mg of dried resin was removed, weighed 
and transferred to a small pyrex vial. The reagents used were a 
combination of the Kaiser solutions such that Reagent A consisted 
of 10 ml of Kaiser 2 mixed with 100 ml of Kaiser 3, while Reagent 
B was the same as Kaiser 1. 100 yl of Reagent A and 25 yl of 
Reagent B were added to the vial containing the granules and to 
an empty vial. The vials were heated at 100°C in an oven for 10 min 
and then cooled in cold water. The colour was washed from the 
resin with 60% ethanol and the washings were pooled and made up 
to 5 ml in a graduated flask. The absorbance of this solution was 
measured at 570 nm using a Cecil 272 spectrophotometer. The number
of amino groups attached to the resin was calculated as follows
1. Concentration of Amine = ^ S570 —
15,000 M
2. Number of moles of „ ^= Concentration x 5.0amine -------— — —-------- mol1,000
3. Number of amino groups ^
e *  = No. of moles x 1,000 ,
on the resin — - L'l— — ■ --- meq/gWeight of Resin M e
4. Percentage Loading = No. of amino groups „^  n/
0^2 X 100 /o
Completion of Assembly and Deprotection
N-terminal deprotection was required for the final residue 
of [Tyr^]M-AKH but not for the other peptides which were 
terminated by a pyroglutamate residue which lacked an Fmoc group.
The completed peptide, still attached to the resin was washed with 
25 ml of tertiary amyl alcohol (t-amyl alcohol); 25 ml of glacial 
acetic acid; 25 ml of t-amyl alcohol; 50 ml of diethyl ether; dried 
under nitrogen and stored in a weighing vial at -30°C.
The resin was reequilibrated to room temperature prior to 
the removal of the side chain protecting groups by 95% trifluoroacetic 
acid (TFA) in water. The resin was mixed with the acid in a sintered 
tube by bubbling with nitrogen to ensure constant mixing for 20 min. 
The acid was changed twice and mixing continued for a further 20 min 
each time. The deprotected peptide was then washed with t-amyl 
alcohol; DMF; 10% ethyldiisopropylamine in DMF; DMF; t-amyl alcohol; 
DMF and ether (30 ml of each solvent was pumped through the resin 
at a flow rate of 2 ml/min). The resin was then dried under 
nitrogen and desiccated overnight over phosphorus pentoxide at 
room temperature.
Cleavage of the Peptide from the Resin
30 ml of methanolic ammonia was prepared by bubbling ammonia 
through aluminium oxide-dried methanol on ice for 1 h. The resin 
was placed in a round bottomed flask and swollen with a few drops 
of DMF. The methanolic ammonia was added to the resin and the flask 
was immediately sealed with a septum cap pierced with a syringe 
needle attached to a balloon to allow for changes in pressure 
within the flask. The mixture was left at room temperature for 
4 h with occasional swirling of the flask to ensure maximum 
exposure of the resin to the cleavage solution. Using a Pasteur 
pipette the resin was then removed, washed with dried methanol
and the washings pooled with the methanolic ammonia containing
the cleaved peptide. The crude peptide solution was dried down
on a rotary evaporator, resuspended in 10% acetonitrile and loaded
onto a primed CL SepPak cartridge (Waters Associates, Milford,18
U.S.A.). The material eluted from the SepPak between 10% and 
60% acetonitrile was lyophilised and resuspended in approximately 
500 yl of 10% acetonitrile ready for HPLC purification. Meanwhile 
the cleaved resin was washed with 20 ml of t-amyl alcohol; glacial 
acetic acid; t-amyl alcohol; DMF; ether; dried under nitrogen and 
stored at -30°C.
Purification of the Synthetic Peptides
A Gilson HPLC system was used for the purification of the
synthetic peptides. The system consisted of two Model 302 pumps,
a Model 702 gradient manager, a Model 802 manometric module, a
Model HM Holochrome u.v. detector (all from Gilson International,
Villiers-le-Bel, France), a Rheodyne 7125 injection valve and
a Rikadenki chart recorder. The gradient manager was operated
through an Apple II microcomputer.
The crude peptide was purified by RP-HPLC on a semi-preparati
Spherisorb 5 ym C column (30 cm x 0.8 cm, HPLC Technology Ltd., 
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Macclesfield, U.K.). Solvent A was 0.1% TFA in water, solvent 
B was 0.1% TFA in acetonitrile (TFA was redistilled in the School 
of Chemistry, University of Bath; acetonitrile was obtained from 
Rathburns, Walkerburn, U.K.). The flow rate used was 2 ml/min 
and the gradient conditions were: 15% B (0-5 min); 15-40% B 
(5-15 min); 40-60% B (15-35 min); 60-15% B (35-40 min), followed
by a 15 min reequilibration period. The eluate was monitored at 
210 nm for small samples or 254 nm for larger samples. The major 
peak was collected manually and lyophilised in a Speed Vac concen­
trator (Savant Instruments, Hicksville, U.S.A.).
Analysis of the Purified Peptides
The purified peptides were analysed by RP-HPLC, fast atom
bombardment mass spectrometry (FAB-MS) and amino acid analysis.
The mass spectrometry was performed by Shell Research Ltd.,
Sittingbourne, U.K., by courtesy of Dr. P. Jewess on a Finnigan
MAT-90 mass spectrometer. The sample was loaded in a thioglycerol
matrix and bombarded with xenon gas at an energy of 8 K.ev.
HPLC analyses were performed on a Spherisorb 5 ym C analytical18
column (0.46 x 25 cm, HPLC Technology). The flow rate used was 
1 ml/min and the eluate was monitored at 210 nm. For the analysis 
of M-AKH and [Tyr^]M-AKH the solvents were the same as those used
r 4 ifor the purification, however for the analysis of [IodoPhe JM-AKH 
solvent A was 0.05 M NaH^PO^ adjusted to pH 3.3 with concentrated 
phosphoric acid and solvent B was 0.05 M NaH^PO^ in 60% acetonitrile, 
adjusted to pH 3.3 as above. Several gradients were used for the 
analyses. The gradient for M-AKH analysis was 10% B (0-5 min);
10-60% B (5-30 min); 60% B (30-35 min); 60-10% B (35-40 min).
For [Tyr^M-AKH the gradient was 15-40% B (0-20 min); 40-60% B 
(20-30 min); 60% B (30-35 min); 60-15% (35-40 min), and for 
[Iodo-Phe^]M-AKH the gradient was 20-100% B (0-30 min); 100% B 
(30-33 min); 100-20% (33-33.1 min).
For the amino acid analysis 10-20 nmol of peptide was 
lyophilised in an acid-washed pyrex test tube and then dissolved in 
6 N HC1 (Aristar grade). The tube was drawnout over a flame to 
produce a narrow neck and placed in dry ice/ethanol to freeze the 
sample. The tube was removed from the dry ice/ethanol and evacuated 
on an oil pump as the sample thawed. When the evacuation was 
completed the tube was sealed over a flame and incubated at 105°C 
for 24 h to hydrolyse the peptide into its constituent amino 
acids. The top of the vial was then removed and the hydrolysate 
dried down overnight in a vacuum desiccator. The sample was 
resuspended in 200 yl of 25 mM HC1 and injected into a Hilger 
Chromaspek II amino acid analyser. The eluate from the analyser was 
monitored at 570 nm. For the analysis of the resin during the 
synthesis of the analogues, a weighed sample of resin was placed in 
an acid-washed tube and hydrolysed as described above.
Bioassay of the Peptides
The adipokinetic activity of the purified peptides was 
determined in adult Manduca. A 10 yl sample of peptide at a known 
concentration was injected into the moth immediately after the 
removal of a 5 yl sample of haemolymph. A second sample of 
haemolymph was obtained after 100 min and the change in the level 
of total haemolymph lipids was determined by a sulphophospho- 
vanillin method modified from Goldsworthy et al. (1972) and 
described in Chapter 4.
r 4 iHydrogenation of [IodoPhe J M-AKH
The [IodoPhe4 ] analogue of M-AKH was synthesised with the
intention of producing a specifically tritiated analogue of M-AKH 
3  4 i[ H-Phe JM-AKH by catalytic reduction with tritium gas. A number of 
preliminary hydrogenation experiments were performed in order to 
optimise the requirements for the catalytic reduction of
r 4 i[IodoPhe JM-AKH. The most successful of these experiments 
incorporated the following procedure. 5 mg of 10% palladium on 
calcium carbonate catalyst (British Drug Houses (BDH), Poole, U.K.) 
was washed in DMF. The catalyst was separated by centrifugation, 
resuspended in 1 ml of fresh DMF and added to 2 ml of DMF
r 4 icontaining 8 yg of [IodoPhe JM-AKH in a round bottomed flask. The
flask was perfused with hydrogen for 10 min and then stirred for a
further 2 h under an atmosphere of hydrogen. The mixture was then
placed in a polypropylene centrifuge tube and spun at 2,000 r.p.m.
in an MSE Centaur S bench centrifuge. The supernatant was removed
and the pellet washed in DMF. The pooled supernatant and washings
were lyophilised, resuspended in 10 ml of 20% methanol and loaded
onto a primed C  SepPak cartridge. The fraction eluting between lo
20% and 60% methanol was collected, lyophilised and resuspended in 
200 yl of 20% acetonitrile for HPLC analysis.
The success of the hydrogenation was assessed by the same HPLC 
method described above for the analysis of purified 
[IodoPhe^]M-AKH. The eluate was monitored at 210 nm.
RESULTS
A sample of the crude product of the M-AKH synthesis separated
by RP-HPLC, is shown in Fig. 2.2a. The major peak was collected and 
analysed in order to confirm its identity with M-AKH. Analytical 
HPLC of the material from the collected peak revealed a single peak 
(Fig. 2.2b) which coeluted with a sample of synthetic M-AKH 
supplied by Dr. R. Keller, University of Bonn, F.R.G. (data not 
shown). The single peak indicated a successful purification, 
however coelution with a peptide of known sequence is not 
sufficient evidence to confirm the identity of the purified 
peptide, so further characterisation was undertaken.
The FAB-MS spectrum of the purified synthetic peptide is shown
in Fig. 2.3a which illustrates a scan of the mass to charge ratios
(m/z) in the range 1000-1200 Daltons. The principal peak at m/z
1008.6 is consistent with the molecular ion [ M+H]+ for M-AKH which
has a mass of 1008 Daltons. The peak at m/z 1172.2 is the rCs_lJ +L 5 4J
internal standard. The peak at m/z 1030.5 is interpreted as the 
[ M+Na ]+ ion.
The peptide therefore has the appropriate HPLC characteristics 
and molecular mass for M-AKH but these results do not reveal any 
details about the amino acid composition of the peptide. Fig. 2.3b 
shows the amino acid analysis of the synthetic peptide. Tryptophan 
is labile under the hydrolysis conditions used so that its presence 
is inferred by comparison with the HPLC and FAB-MS data. The 
peptide consists of 2 Thr, 2 Ser, 1 Glu, 1 Gly, 1 Leu and 1 Phe 
residue which, apart from the absence of Trp is consistent with the 
peptide being M-AKH.
The quantitative Kaiser test was performed on samples of resin 
coupled with the Gly anhydride for the synthesis of the M-AKH
analogues. The results indicated a very low coverage of the resin 
(25%) and repetition of the coupling produced no significant 
increase in the apparent percentage coverage. Weighed samples of 
the resin were then deprotected and amino acid analysed (Table 
2.1). This analysis, contrary to the Kaiser test, indicated 
complete coverage of the resin with an absolute loading of 0.13 
meq/g for glycine and 0.12 meq/g for the resin standard norleucine 
consistent with the loading of 0.12 meq/g specified by the 
manufacturer. It was assumed that the amino acid analysis was more 
reliable than the Kaiser test and the synthesis was continued.
The purification of [Tyr^]M-AKH is illustrated in Fig. 2.4. The
purified peptide eluted 3.5 min after M-AKH indicating a different
chemical identity for this peptide. The FAB-MS spectrum for this
peptide (Fig. 2.5a) shows a molecular ion at m/z 1060.6 which is
consistent with the [M+H]+ ion for [Tyr^ ] M-AKH. The peak at m/z
1082.7 is probably due to the [M+Na f ion whilst the small peak at
m/z 1044.6 is consistent with the acylium ion formed by the loss of
NH^ from the C-terminal amide. Amino acid analysis revealed the
following amino acid composition for the peptide: 2 Thr, 2 Ser, 1
Gly, 1 Leu, 1 Tyr, 1 Phe. The norleucine peak is due to the
presence of this amino acid as an internal standard during this
analysis (Fig. 2.5b). In combination these data confirm the
identity of the peptide as [Tyr^jM-AKH.
r 4 iThe synthetic [IodoPhe JM-AKH also eluted later than M-AKH when 
analysed by HPLC (Fig. 2.6b). FAB-MS of this peptide revealed a 
major peak at m/z 1134.5 consistent with the molecular ion [M+H]+ 
for [IodoPhe^]M-AKH. The peak at m/z 1118.5 is interpreted as the
acylium ion for this peptide while the peak at m/z 1156.5 is the 
[ M+Na ]+ ion (Fig. 2.7a). Amino acid analysis revealed the absence 
of a phenylalanine residue and the peak eluting slightly later than 
the trace of histidine is interpreted as the IodoPhe residue (Fig. 
2.7b). The amino acid composition data are therefore consistent 
with the identification of this peptide as [IodoPhe^] M-AKH.
The adipokinetic activity of the three peptides was assayed in 
adult Manduca (Table 2.2). M-AKH caused an increase of 33 mg/ml at 
both of the test doses and it was therefore assumed that this 
represented the maximum response. [Tyr^] M-AKH did not produce a 
significant change in the level of haemolymph lipid when compared 
with the control. [IodoPhe^]M-AKH elicited an increase equivalent 
to approximately 50% of the maximum response, at a dose of 20 pmol 
however the response to 5 pmol was not significantly different to 
that of control insects. It would appear that the N-terminal 
pyroglutamate residue is vital for adipokinetic activity whereas
4
the replacement of a hydrogen atom with an iodine atom at the Phe 
position reduces but does not remove all the adipokinetic activity.
The results from the hydrogenation experiments varied greatly. 
The most successful experiment is illustrated in Fig. 2.8. In a
rcontrol flask the [IodoPhe J analogue was mixed with washed 
catalyst but not exposed to hydrogen. The peptide was less easily 
recovered than from the experimental flask and the peptide peak 
corresponded with the unreacted analogue (Fig. 2.8a). In the 
experimental sample the broad peak shown in Fig. 2.8b is believed 
to be due to contamination from the DMF. The peptide peak coeluted 
with M-AKH approximately 2 min earlier than the [IodoPhe^ ]
analogue. HPLC analysis suggests virtually complete hydrogenation 
of the peptide and a yield of approximately 40%. Unfortunately this 
result was not reproducible and the use of dithiothreitol to poison 
the catalyst also failed to improve the procedure.
DISCUSSION
Locust adipokinetic hormone (AKH-I) has been synthesised by a 
variety of techniques since it was sequenced in 1976. Broomfield 
and Hardy (1977) synthesised the N-terminal hexapeptide by a solid 
phase method using tertiary butoxycarbonyl (tBoc) amino acid 
derivatives (see Merrifield, 1986) and coupled this fragment to the 
C-terminal tetrapeptide which had been synthesised in solution by 
stepwise addition of amino acid residues to threonine amide. 
Yamashiro et al. (1981) synthesised AKH-I using solid-phase 
chemistry only whereas Kisfaludy et al. (1986) synthesised AKH-I 
using a pentafluorophenyl ester solution method. The latter group 
protected the threonine residues in the assembled peptide with 
benzyl groups. Unfortunately they were unable to remove all of 
these by catalytic hydrogenation without observing partial
g
saturation of the indole ring of the [ Trp ] residue. Consequently
5
[Thr(Bzl) ]AKH-I was a major by-product of this synthesis.
Analogues of AKH-I were synthesised and produced by enzymatic 
cleavage of synthetic AKH-I by Stone et al. (1978) for use in the 
investigation of structure-activity relationships. Hardy and 
Sheppard (1983) synthesised two analogues of AKH-I containing 
modified amino acid residues by solid-phase and solution methods 
for use as precursors of a tritiated analogue of AKH-I. Recently,
Moshitzky et al. (1987) synthesised [ Glu^ ] AKH-I by a tBoc solid 
phase method for use in the preparation of a radioiodinated 
analogue of AKH-I.
Solid-phase peptide synthesis using Fmoc chemistry has a number 
of advantages over solution synthesis or tBoc methods. Solid-phase 
synthesis by Fmoc or tBoc chemistry is likely to produce a higher 
yield of peptide than solution synthesis because the peptide is 
secured on the resin and therefore losses during the assembly due 
to the transfer of solutions between flasks are greatly reduced. 
Excess reagents are easily separated from the peptide using a 
continuous-flow system as described by Dryland and Sheppard (1986). 
Solid-phase synthesis using tBoc chemistry requires the use of 
corrosive reagents such as hydrogen fluoride which is commonly used 
for side-chain deprotection and cleavage of the peptide from the 
resin on completion of the assembly (Merrifield, 1986). Fmoc 
solid-phase synthesis is accomplished with milder reagents. The 
Fmoc group is removed by 20% piperidine in DMF, whereas tBoc groups 
are removed by 50% trifluoroacetic. acid (TFA) in DCM. Side-chain 
deprotection and peptide cleavage from the resin, as reported here, 
were achieved using 95% TFA in water and methanolic ammonia, 
respectively. The separation of the deprotection and cleavage steps 
reduced the risk of unwanted reactions between the exposed side 
chains and components of the reaction mixture as the latter 
solution was circulated through the resin rather than mixed with it 
in a flask. Atherton et al. (1983) synthesised 3-endorphin by the 
tBoc and Fmoc methods and observed a fourfold increase in yield and 
enhanced purity using the Fmoc system.
The insect peptide M-AKH and two nonapeptide analogues were 
successfully synthesised using a solid-phase Fmoc method. The 
assembly was readily monitored by u.v. absorbance of the 
circulating solvent and the qualitative Kaiser test for the 
completion of each coupling step was easily performed and caused 
minimal disruption of the synthetic process. Unfortunately the 
quantitative Kaiser test did not appear to be reliable in this 
instance. It has been successfully applied in the assessment of 
coupling to other Pepsyn resins (R.G. Kinsman, personal 
communication), but the result obtained for the coupling of glycine 
anhydride to the Pepsyn KB resin was not in agreement with amino 
acid analysis data. The final yield and purity of the crude peptide 
analogues suggested that the low percentage coverage indicated by 
the Kaiser test was not correct. The reason for the failure of the 
quantitative Kaiser test is not known.
The structural identities of the three peptides was confirmed 
by RP-HPLC, amino acid analysis and FAB-MS. A preliminary bioassay 
of synthetic M-AKH for adipokinetic activity indicated bioactivity 
corresponding with that of natural M-AKH (R. Keller, personal 
communication). Both of the analogues were inactive at doses below
5 pmol and the [Tyr^ ] analogue was also inactive at a dose of
20 pmol. These results will be further discussed in a subsequent
chapter on the pharmacology of the M-AKH receptor.
[IodoPhe^]M-AKH was synthesised to act as a substrate for the 
preparation of a specifically tritiated analogue of M-AKH. 
Unfortunately I was unable to optimise the conditions for the 
catalytic reduction of the analogue. Consequently a tritiated
analogue of M-AKH has yet to be produced. [Tyr1] M-AKH was 
synthesised to act as a substrate for the production of an M-AKH 
antigen following conjugation to thyroglobulin. The production of 
such an antigen and the development of a radioimmunoassay using 












Fig. 2.1 Diagrammatic representation of the Pepsynthesiser II 
system. Reagent A is DMF; reagent B is 20% piperidine 
in DMF. Dotted lines indicate alternative flow 
routes.
Fig. 2.2. a) HPLC purification of synthetic M-AKH. A sample of 
crude peptide was loaded onto a Spherisorb 5 ym Clo
column (30 cm x 0.8 cm) and eluted by a gradient 
indicated by the dotted line. Solvent A was 0.1% 
TFA; solvent B was 0.1% TFA in acetonitrile. The 
flow rate was 2 ml/min.
b) HPLC analysis of purified synthetic M-AKH. The
sample was loaded onto a Spherisorb 5 ym C columnlo
(25 cm x 0.46 cm) and eluted by a gradient indicated 
by the dotted line. The solvents were the same as in
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Fig. 2.3. a) Fast atom bombardment mass spectrometry (FAB-MS) of 
synthetic M-AKH. The peptide sample was loaded in a 
thioglycerol matrix and bombarded with Xenon gas in 
a Finnigan MAT-90 spectrometer. Mass to charge 
ratios (m/z) in the range 1000-1200 were scanned.
Ion abundances are expressed in terms of absolute 
(right ordinate) and relative values (left 
ordinate).
b) Amino acid analysis of a sample of synthetic M-AKH, 
following hydrolysis for 24 h in 6 N HC1 in vacuo. 
The analysis was performed by a Hilger Chromaspek II 
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Table 2.1. Amino acid analysis of the initial coupling step in 
the synthesis of the two analogues. The values were 
calculated from the peak heights of the glycine 
residue and the norleucine resin standard and 
calibrated from the values for a standard mixture of 
amino acids.






Fig. 2.4. HPLC purification (a) and analysis (b) of [Tyr^] M-AKH.
The chromatographic details were the same as in Fig. 2.2 
except for the gradient used in b) indicated by the 
dotted line. For the analytical run a sample of’
[ Tyr^]M-AKH was loaded onto the analytical column 
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Fig. 2.5. a) FAB-MS of [Tyr^jM-AKH. Details as in Fig. 2.3.
b) Amino acid analysis of [Tyr^]M-AKH. The hydrolysed 
sample was analysed with a norleucine reference 
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Fig. 2.6. HPLC purification (a) and analysis (b) of
[IodoPhe4]M-AKH. Chromatographic conditions as in Fig. 
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Fig. 2.7. a) FAB-MS of [IodoPhe^]M-AKH. Details as in Fig. 2.3.
b) Amino acid analysis of [IodoPhe^]M-AKH. The details 
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Increase in Haemolymph 
Lipids (mg/ml)
n
M-AKH 2.0 33.0 ± 2.0* 4
10.0 33.5 ± 7.5* 4
[IodoPhe4]M-AKH 5.0 7.9 ± 1.8 8
20.0 17.1 ± 3.0* 7
[Tyr1]M-AKH 20.0 5.9 ± 1.8 7
Response expressed as the mean ± SE for n samples. Asterisks 
indicate a significant increase compared with control injections 
of 10% acetonitrile (5.5 ± 1.0, n = 4) as determined by a t-test
(p < 0.01).
Fig. 2.8. r 4 iTrial hydrogenation of [IodoPhe JM-AKH.
a) Control. HPLC analysis of peptide following exposure 
to Pd/CaCOg catalyst in DMF under a normal 
atmosphere. The major peak coeluted with 
[IodoPhe4 ]M-AKH.
b) Experimental. HPLC analysis of peptide following 
exposure to Pd/CaCO^ catalyst in DMF perfused with 
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CHAPTER 3. A RADIOIMMUNOASSAY FOR M-AKH AND ITS USE
IN M-AKH QUANTIFICATION
INTRODUCTION
The amount of peptide hormone contained within a tissue may be 
determined by a variety of techniques, including bioassay, 
chromatography (particularly reversed-phase HPLC) and radio­
immunoassay (RIA). Some of these techniques have been used for the 
determination of the AKH-I content of tissues, principally the 
corpora cardiaca (CC), from locusts. Stone et al. (1976) calculated 
the recovery of AKH-I from Locusta and Schistocerca from the amino 
acid content of tissue extracts and used this information to 
estimate the AKH-I content of Locusta and Schistocerca CC. Van 
Marrewijk et al. (1983) compared the bioactivity of CC extracts 
with that of synthetic AKH-I to obtain an estimate of the AKH-I 
content of Locusta CC. The most extensive quantification to date, 
was performed by Siegert and Mordue (1986) using reversed-phase 
HPLC. They determined the AKH-I and AKH-II content of CC from male 
and female locusts during the last larval instar and during 
adulthood.
Peptides may be quantified by radioimmunoassay at levels which 
cannot be detected by other techniques. Radioimmunoassays have been 
developed for the investigation of AKH-I biosynthesis in the CC 
(Hekimi and O'Shea, 1987) and in the brain (Moshitzky et al.,
1987a, 1987b) but only one of these studies included any data on 
the AKH-I content of CC and brain (Moshitzky et al., 1987a).
I have raised an antiserum for M-AKH and have used it in the 
development of a specific RIA for M-AKH. The RIA has been used to 
determine the M-AKH content of larval and adult CC and neural 
tissue from Manduca. The results will be compared with RP-HPLC data 
for the M-AKH content of adult CC.
MATERIALS AND METHODS 
Experimental Animals
The animals used in this project were from a laboratory culture 
of Manduca sexta maintained on artificial diet according to Bell 
and Joachim (1976), under a long day (LD, 17:7) photoperiodic 
regime.
Preparation of Tissue Extracts
Brain, abdominal nerve cord and CC extracts were prepared from 
adult and larval tissues. Adult tissues were obtained from day 2 
moths of both sexes (which are of similar size). Larval tissues 
were obtained from day 3, fifth instar larvae (also unsexed). The 
extraction method was slightly modified from that reported by Jaffe 
et al. (1986) for the extraction of the adipokinetic hormone from 
the corn earworm, Heliothis zea.
Tissues were excised, rinsed briefly in insect saline (Ephrussi 
and Beadle, 1936), blotted lightly on filter paper and placed in 
1.5 ml polypropylene tubes on ice. Each tissue sample was 
homogenised in 50-200 \xl of extraction solvent (methanol : water : 
glacial acetic acid, 90:9:1) in a small glass homogenizer and then 
centrifuged at 12,000 r.p.m. for 5 min in an Eppendorf 5415 micro­
centrifuge. The supernatant was removed and the pellet reprocessed
through the homogenization and centrifugation steps. Pooled
supernatants were freeze-dried in a Speed Vac concentrator and
resuspended in 1 ml of 0.1% TFA. Ethyl acetate (3 x 500 yl) was
mixed with the TFA solution to extract any lipids from the sample.
The ethyl acetate fraction separated out above the TFA solution and
was removed with a pipette. Any residual ethyl acetate was removed
under nitrogen and the sample was then applied to a C SepPak
18
cartridge primed with 10% acetonitrile. The sample was washed with 
10% acetonitrile and eluted by a 60% acetonitrile wash. The eluate 
was lyophilized and resuspended in 10% acetonitrile or RIA buffer 
for HPLC or RIA titre determination.
Haemolymph M-AKH Titre Determination
Haemolymph M-AKH titres were determined in starved and fed 
larvae. All larvae were manually removed from the artificial diet 
on which they were reared. The control insects were immediately 
replaced on diet, whereas the experimental insects were placed in 
empty plastic cups.. The larvae were then placed in an incubator at 
25°C for different lengths of time prior to haemolymph extraction. 
Any faecal pellets produced during the experiment by the starved 
larvae were removed to prevent coprophagy.
Larvae were rapidly anaesthetized with C0^ and then bled by 
removal of the abdominal horn. 1 ml of haemolymph was collected 
from each larva in a polypropylene tube containing a few crystals 
of P.T.U. Each sample was rapidly frozen in dry ice/ethanol and 
then placed in a boiling water bath for 3 min. The freezing step
was included to prevent the enzymatic degradation of any released
peptide by haemolymph proteases (see Chapter 6) and the boiling
step precipitated haemolymph proteins. Boiled samples were
centrifuged at 2,000 r.p.m. for 5 min in Beckman J-6 centrifuge
and the supernatant was then removed and applied onto a primed C.0lo
SepPak cartridge. The material eluting between 10% and 60% 
acetonitrile was collected and lyophilised. Each haemolymph extract 
was resuspended in 50 pi of RIA incubation buffer and assayed.
HPLC Analyses
The M-AKH titre of adult CC extract was determined by RP-HPLC
using the Gilson system described in the previous chapter. A
Spherisorb C 5 pm analytical column (0.46 x 25 cm, HPLC lo
Technology) was used for the quantification. The flow rate was 
1 ml/min and the solvents used were: A, 0.1% TFA; B, 0.1% TFA in 
60% acetonitrile. The gradient conditions for the quantification 
were: 33-77.5% B (0-20 min), 77.5-100% B (20-20.1 min), 100% B 
(20.1-25 min), 100-33% B (25-25.1 min) followed by a reequili­
bration period of 15 min at 33% B. The eluate was monitored by u.v. 
absorbance at 210 nm. Peak areas were calculated by a Gilson Model 
620 Data Master. Synthetic M-AKH standards were used to calibrate 
the system and to indicate the elution time for M-AKH under the 
above conditions.
In a subsequent experiment to determine the elution time of the 
M-AKH-immunoreactive material, a sample of CC or brain extract was
injected onto a Spherisorb C 5 pm column (as above). The solventslo
and flow rate were the same as those described above, however the
sample was eluted by a linear gradient of 20-90% solvent B over 
40 min. Fractions were collected in 4 ml polypropylene tubes at 1 
min intervals using a Gilson Model 201-202 fraction collector. An 
aliquot from each fraction was removed, lyophilised and then 
resuspended in RIA buffer (aliquots outside the region of interest 
were pooled prior to lyophilisation).
Preparation of Radiolabelled [Tyr1] M-AKH
1 Mg of [Tyr^jM-AKH was radioiodinated by a chloramine-T method
previously used for the iodination of the trout melanophore
concentrating hormone, MCH (Eberle, 1987). The iodination procedure
was performed in a fume cupboard specifically designated for that
125purpose. 10 pi of Na I (1 mCi, Amersham International, Amersham,
U.K.) was pipetted into a 1.5 ml polypropylene tube and stored in a
lead castle. 20 pi of 0.25 M phosphate buffer, pH 7.4 was added to
the isotope followed by 1 pg of [Tyr^ ] M-AKH in 10 pi of 10%
acetonitrile and 15 pi of chloramine-T solution (5 mg/10 ml of 0.25
M phosphate buffer, pH 7.4 prepared immediately before use). The
iodination cocktail was mixed immediately and then left to stand
for 30 sec. Termination of the iodination was achieved by the
addition of 600 pi of 0.05 M phosphate buffer, pH 7.4 containing
0.25% BSA and 0.1% 8-mercaptoethanol.
A SepPak protocol was used to separate the labelled peptide 
125from free Na I (it was assumed that all the unlabelled peptide
had been iodinated by the large excess of isotope). A C1Q SepPak
lo
cartridge had been primed, before the iodination, by washes of 1% 
TFA (3 x 600 pi); 80% methanol (3 x 600 pi); 20 mg/2 ml polypep
(from Sigma) in 0.05 M phosphate buffer, pH 7.4 (1 x 600 yl); 80% 
methanol (3 x 600 yl) and 1% TFA (3 x 600 yl). The iodination 
mixture was applied to the primed SepPak and the eluate was 
reapplied and collected. The SepPak was then washed with 0.25 M 
phosphate buffer (2 x 600 yl) followed by a graded series of 
methanol solutions in 1% TFA, from 30% to 80% methanol with 5% 
intervals between each concentration. For each concentration the 
SepPak was washed three times with 600 yl of solution and the 
eluates were collected separately in polyproylene tubes. A 10 yl 
aliquot from each tube was counted for 6 sec in a Type N550A 
scintillation counter (Ecko Electronics Ltd., Southend, U.K.) to 
determine which fractions contained the labelled peptide. The 
peptide-containing fractions were diluted with 3 ml of 50% methanol 
and 3 ml of termination buffer and stored in sealed polypropylene 
tubes at -20°C.
Conjugation of [Tyr*]M-AKH to Thyroglobulin
Two conjugation procedures were employed using different 
linking agents to conjugate the peptide to bovine thyroglobulin.
Method A . 2 mg (2 ymol) of [Tyr^]M-AKH was dissolved in 1.5 ml of 
0.1 M phosphate buffer, pH 7.5, with the addition of a few drops of 
DMF to ensure complete dissolution. 50 mg of thyroglobulin was 
added to the peptide solution and the mixture placed on ice. 1.6 ml 
of 0.02 M glutaraldehyde in 0.1 M phosphate buffer, pH 7.5 was 
added in 300 yl aliquots over a 15 min period. The mixture was 
shaken regularly during this period and then left to incubate
overnight at 4°C' The conjugated mixture was dialysed for 24 h 
against 0.1 M phosphate buffer, pH 7.4 and against distilled water 
for a further 24 h. The dialysed conjugate was then lyophilised and 
stored in a desiccator at -20°C. The estimated molar ratio of 
protein : peptide : glutaraldehyde was 0.037:1:16, therefore 1 mg 
of peptide should have been present in 25.9 mg of conjugate.
Method B. This procedure is based upon that used by Schooneveld 
et al. (1983) for the conjugation of [Tyr^jAKH-I to thyroglobulin. 
1.8 mg (4 ymol) of bis(2-[succinimidooxycarbonyloxy]ethyl)-sulphone 
(BS0C0ES, purchased from Pierce U.K. Ltd., Cambridge, U.K.) was 
dissolved in 120 ul of DMF together with 2 mg (2 ymol) of 
[Tyr^]M-AKH. After 2 min this mixture was added to 40 mg of 
thyroglobulin in 1.2 ml of 0.01 M phosphate buffer, pH 7.4. The 
mixture was incubated at room temperature for 75 min and then 
dialysed overnight against distilled water. The dialysed material 
was then lyophilised and stored in a desiccator at -20°C. The 
estimated molar ratio of protein : peptide : BS0C0ES was 0.03:1:2 
therefore 1 mg of peptide should have been present in 20.6 mg of 
conjugate.
Immunization Protocol
Two male Sandy half-lop rabbits were injected with conjugated 
peptide. 5 mg of conjugate (approximately 200 yg of peptide 
equivalent) was dissolved in 1 ml of 0.05 M phosphate buffered 
saline, pH 7.2, emulsified in 2 ml of complete Freund's adjuvant 
(Sigma) and injected into each rabbit at multiple sites
intramuscularly. The primary immunization was repeated two weeks 
later and booster injections of 180-200 yg of peptide equivalent, 
emulsified in 2:1 incomplete Freund's adjuvant : phosphate buffered 
saline were administered at fortnightly intervals. Serum samples 
were obtained by ear-bleeding the rabbits 8-10 days after each 
injection.
Peptide conjugated according to Method A was used for the
primary immunizations and earlier boosts. When the supply of this
conjugate was exhausted Method B conjugate was administered. The
anti-M-AKH response was assessed by the ability of serum to 
125 1precipitate [ I-Tyr ]M-AKH. When the titre of antibody was 
suitably high the rabbits were anaesthetised with halothane and 
exsanguinated by cardiac bleeding. The blood was collected in pyrex 
beakers and left to stand at room temperature for 2 h. The 
coagulated blood was then placed at 4°C to encourage contraction of 
the clot. The final serum was divided into 1 ml aliquots and stored 
at -70°C.
Radioimmunoassay for M-AKH
A radioimmunoassay was developed by the modification of 
protocols previously developed for the assay of MCH (Dr B.I. Baker, 
personal communication) and AKH-I (Moshitzky et al., 1987a). The 
incubation buffer used for the dilution of the serum, labelled 
peptide and test samples consisted of 0.05 M phosphate buffer 
pH 7.4 containing 0.25% BSA, 0.01% thiomersal and 0.001% 
poly-L-lysine (m.wt. 4,000-15,000). The incubation mixture 
contained 50 yl of buffer (or sample in later experiments), 50 yl
of diluted serum and 50 pi of labelled peptide (9,000 c.p.m.). In 
order to assess the antibody titre each serum sample was serially 
diluted in incubation buffer. The RIA mixture was incubated 
overnight at 4°C and terminated by the addition of 500 yl of 
charcoal solution (0.05 M phosphate buffered saline containing 0.1% 
gelatine, 0.125% dextran, 0.01% thiomersal and 0.5% activated 
charcoal, pH 7.4 at 4°C). The terminated mixture was incubated at 
4°C for 7-8 min and centrifuged at 4,500 r.p.m. for 15 min in a 
Beckman J-6 centrifuge. The supernatant containing labelled peptide 
bound to antibody was aspirated from each tube and the pellet, 
containing free labelled peptide bound to charcoal, was counted in 
an LKB 1275 Minigamma counter.
All assays included controls lacking antibody or unlabelled 
peptide. In order to test the specificity of the assay, a number of 
other insect peptides were assayed for cross-reactivity. These were 
obtained from the following sources: AKH-I from Peninsula 
Laboratories, St. Helens, U.K.; AKH-II(L) from Professor W. Mordue, 
University of Aberdenn, U.K.; M-II from Professor M. O'Shea, 
University of Geneva, Switzerland; HTF-II from Dr. G. Gade, 
University of Dusseldorf, FRG; Leucokinins II and VI (LKII and 
LKVI) from Dr. G.M. Holman, U.S. Dept, of Agriculture, College 
Station, U.S.A.
RESULTS
The M-AKH content of adult and larval tissues was determined by 
HPLC and RIA analysis. The contents of less than 10 adult CC pair 
equivalents were detectable by u.v. absorbance of the HPLC eluate
(Fig. 3.1a). A single major peak was observed which coeluted with a 
sample of synthetic M-AKH (Fig. 3.1b). A standard curve was 
obtained for the peak areas of varying amounts of synthetic M-AKH 
injected in 100 pi of 10% acetonitrile (Fig. 3.2). Two samples 
containing 3.9 and 7.8 CC pair equivalents were analysed and the 
peak areas indicated titres of 19.0 and 19.9 ng/CC respectively.
The M-AKH content of larval CC extract was not detectable using 
similar quantities of extract.
A radioimmunoassay was developed to provide a more sensitive
assay for the detection of M-AKH in larval and adult tissues. The
results of the radioiodination of [Tyr^ j M-AKH are illustrated in
125Fig. 3.3. The majority of the radioactivity (free Na I) was 
eluted from the SepPak by the initial washes. Another peak of 
radioactivity was eluted by the 55% methanol washes. This peak 
represented the radiolabelled M-AKH analogue and fraction 55^ was 
used in the RIA experiments.
The first attempt to raise antibodies to M-AKH utilised 
conjugate produced by Method B. This material was injected into 
three Californian White rabbits but failed to evoke a suitable 
response. The failure of this attempt may have been due to an 
underestimate of the amount of conjugate required for each 
injection, based on the molar ratio quoted by Schooneveld et al. 
(1983). A second attempt was made using Sandy half-lop rabbits 
initially injected with conjugate produced by Method A and 
subsequently with the Method B conjugate. This was more successful 
and Fig. 3.4a shows the titre of antibody (represented as the % of 
labelled peptide bound to antibody) from the serum of rabbit number
158 following the terminal bleed. The maximum binding observed was 
only 40%, however there was sufficient immunoreactivity for the 
development of an RIA. A final serum dilution of 1 in 1800 was used 
in subsequent experiments. The sensitivity and specificity of the 
RIA are illustrated in Fig. 3.5b. The displacement of bound 
labelled peptide by unlabelled M-AKH indicated that the assay could 
be used for the detection of 40-400 pg of M-AKH. A number of other 
insect peptides were also assayed for cross-reactivity with the 
M-AKH antiserum. Several members of the AKH/RPCH family (AKH-I, 
AKH-II(L), M-II and HTF-II) failed to displace the labelled M-AKH 
analogue at any concentration tested. However Leucokinin II (LKII, 
Asp-Pro-Gly-Phe-Ser-Ser-Trp-GlyNH^, Holman et al., 1986) a 
cockroach peptide with the same C-terminal sequence as M-AKH, 
caused a modest displacement of the label from the antibody but 
only at a very high concentration (5 ng of LK-II per tube).
The M-AKH RIA was used to determine the amount of M-AKH in 
brain, nerve cord and CC extracts prepared from larval and adult 
Manduca (Table 3.1). The RIA confirmed the HPLC quantification of 
M-AKH in adult CC. The content of the adult CC (21 ng/CC) is ten 
times greater than the content determined for larval CC 
(2.2 ng/CC). Much smaller quantities of M-AKH immunoreactivity were 
detected in the adult brain and abdominal nerve cord extracts (0.67 
and 0.08 ng/tissue, respectively) and in the larval brain and nerve 
cord extracts (0.06 and 0.11 ng/tissue, respectively).
The majority of the immunoreactivity in adult and larval CC 
extracts was contained in the fraction eluting between 25 and 
26 min (Fig. 3.6b). For the adult CC extract this peak of
immunoreactivity corresponded to a u.v.-absorbing peak which 
co-eluted with synthetic M-AKH (Fig. 3.6a). However both extracts 
also display a smaller amount of immunoreactivity in the pooled 
fractions which eluted between 30 and 34 min. There was no 
u.v.-absorbing peak in this region. A u.v. peak at 39jmin did not 
correspond to M-AKH like immunoreactivity. Comparison with blank 
HPLC runs, when no sample was injected, suggested that this peak 
was probably due to a solvent contaminant.
The adult and larval brain extracts did not possess 
immunoreactive material which co-eluted with M-AKH, but they did 
possess some immunoreactive material in the 30-34 min pooled 
fractions (data not shown).
Haemolymph titres of M-AKH in starved and fed larvae were 
measured using the RIA procedure. M-AKH immunoreactive material was 
released into the haemolymph during the first hour of larval 
starvation (Fig. 3.7). The haemolymph concentration of M-AKH 
increased from approximately 120 pg/ml to 300 pg/ml and then 
returned to a resting level of approximately 100 pg/ml within 3 h 
of the onset of starvation. These changes in the haemolymph M-AKH 
concentration would require the secretion into the haemolymph of 
about 180 pg of M-AKH since the haemolymph volume of a day 3 larva 
is about 1 ml. A slight increase in the titre of immunoreactive 
material in the control (fed) larvae during the first hour of the 
experiment may have been a result of handling at the start of the 
experiment.
DISCUSSION
In locusts, AKH-I is synthesised and secreted by intrinsic
neurosecretory cells within the glandular lobe of the CC (Orchard, 
1987). Stone et al. (1976) estimated the titre of AKH-I in the CC 
to be 200-500 pmol in Locusta and 400-700 pmol in Schistocerca CC. 
More recently Siegert and Mordue (1986) used RP-HPLC to determine 
the titres of AKH-I and AKH-II in the CC of Schistocerca and 
Locusta. They confirmed that Schistocerca CC contain more peptide 
than those of Locusta and reported an increasing amount of both 
peptides from the last larval instar through to adulthood. The 
AKH-I content increased from 100-750 pmol/CC in Locusta and from 
200-1200 pmol/CC in Schistocerca. The ratio of AKH-I to AKH-II 
increased from 2:1 in fifth instar Locusta to 6:1 in adult Locusta. 
Female locusts (which are larger than males) generally possessed 
higher amounts of both peptides than males.
Ziegler et al. (1984) used a bioassay to estimate that the CC 
of adult Manduca contained 10-20 times less adipokinetic peptide 
than adult locust CC. The synthesis, storage and release of 
glycogen phosphorylase activating hormone (GPAH), a peptide which 
may be identical to M-AKH (see Chapter 4), has recently been 
demonstrated within the intrinsic neurosecretory cells of the 
larval CC (Ziegler et al., 1988). The data presented here confirm 
both the earlier estimate of the M-AKH content of Manduca CC and 
the importance of the CC as the primary if not the only source of 
M-AKH. As in the locust, a considerable increase in the hormone 
content was observed between the last larval instar and adulthood 
(2.2-21 pmol/CC). This may reflect an increased demand for the 
hormone as a regulator of lipid metabolism during flight (Ziegler 
and Schulz, 1986a). The lower amount of hormone in adult Manduca
compared with the amount of AKH-I in the adult locust probably 
reflects differences between the species in the amount of time 
spent in sustained flight as well as the greater longevity of the 
adult locust (several weeks) compared with the adult moth 
(approximately 1 week).
HPLC analysis of the CC extracts indicated that the majority of 
the immunoreactive material coeluted with M-AKH. This confirmed the 
specificity of the RIA for M-AKH, however there did appear to be 
some cross-reactivity with non-M-AKH material. Both the larval and 
adult CC extracts contained immunoreactive material which eluted 
later than M-AKH from the HPLC column (30-34 min). This material 
may represent a precursor polypeptide or a second AKH-family 
peptide. The latter explanation would be consistent with the 
presence of a second peptide in the CC of other insect species, in 
particular a second peptide recently isolated from the CC of the 
corn earworm moth Heliothis zea (Jaffe et al., 1988b). The 
identification of the unknown material will depend upon further 
HPLC purification and bioassay of the fractions eluted between 30 
and 34 min.
The presence of AKH and AKH-like peptides in the insect brain 
has been the subject of some speculation. Schooneveld et al. (1983) 
using a 'C-terminal specific' antiserum for AKH-I demonstrated 
immunoreactive neurones in the locust brain. A subsequent study 
using an 'N-terminal specific' antiserum for AKH-I suggested that 
the AKH-like material in the locust brain was not AKH-I 
(Schooneveld et al., 1986). An RIA for AKH-I has recently been 
employed to identify two AKH-like factors in the locust brain
(Moshitzky et al., 1987a). One of these factors has been identified 
as AKH-I on the basis of bioassay and RP-HPLC data and its 
synthesis in the brain has been demonstrated (Moshitzky et al., 
1987b). The physiological role of locust brain AKH-I is not known.
The amounts of immunoreactive material determined from Manduca 
brain and nerve cord extracts were much lower than from the CC.
HPLC analysis of the brain extracts indicated the absence of M-AKH 
from larval and adult brains, however the 30-34 min peak of immuno­
reactive material observed in the CC was also apparent in the brain 
extracts. Therefore the immunoreactive material quantified in the 
brain and nerve cord extracts was probably not M-AKH. Brain 
extracts from larval and adult Manduca have been shown to lack 
glycogen phosphorylase activating activity (Ziegler, 1979; Ziegler 
et al., 1988), but the adipokinetic activity of brain extracts has 
yet to be determined. The identification of the unknown immuno­
reactive material in terms of both its structure and its biological 
activity will be an important goal for future work.
The M-AKH immunoreactive material released into the haemolymph 
of starved larvae has not been further characterised in terms of 
its HPLC retention time or biological activity. However the data 
from the other tissue extracts and the cross-reactivity experiment 
(Fig. 3.5) suggest that the RIA is relatively specific for M-AKH.
It would therefore seem reasonable to assume that the immuno­
reactive material quantified in Fig. 3.7 represents M-AKH in the 
haemolymph.
If M-AKH is the same as the larval glycogen phosphorylase 
activating hormone (Ziegler et al., 1987), the M-AKH titre in the
haemolymph of 'resting* larvae was unexpectedly high, apparently 
enough to cause significant activation of larval phosphorylase (see 
Chapter 4). Actually the levels of active phosphorylase in such 
insects are known to be low (Siegert, 1987). The explanation for 
this apparent contradiction may lie in the dynamics of M-AKH 
release, distribution and inactivation. First, it is distinctly 
possible that M-AKH may be rapidly released when the larvae are 
anaesthetised and bled. I have found that 'resting' levels of 
active phosphorylase are high unless great care is taken to 
minimise the trauma of killing and dissecting the insects and the 
time taken for these procedures. Second, the circulation of 
haemolymph in larval Manduca is known to be slow compared with the 
rapidity of the fat body phosphorylase response to injected CC 
extract (Ziegler, 1979). Consequently a dose of 100 pg of M-AKH 
injected into a larval abdomen (the location of the majority of the 
fat body tissue) may be considerably more potent than 100 pg of 
M-AKH dispersed throughout the haemolymph. Third, the activities of 
M-AKH inactivating enzymes in the haemolymph (and possibly in other 
tissues) may result in the non-uniform distribution of M-AKH 
activity throughout the haemocoel (see Chapter 6).
The physiological significance of M-AKH release into the 
haemolymph during the first hour of starvation will be discussed in 
the next chapter. The immunoreactive M-AKH titre declined during 
the second and third hours of starvation indicating the removal of 
M-AKH from the haemolymph, possibly by enzymatic degradation (see 
Chapter 6). The activity of fat body glycogen phosphorylase itself 
appears to decline more slowly, since Siegert (1987) reported a
return to resting levels only after 48 h. My data support the 
suggestion made by Siegert (1988) that phosphorylase inactivation 
is facilitated by the removal of M-AKH from the haemolymph rather 
than a change in the responsiveness of the fat body to circulating 
hormones.
Fig. 3.1. Quantification of native M-AKH by RP-HPLC.
a) Analysis of adult CC extract.(7.8 CC pair
equivalents) loaded onto a Spherisorb 5 |im C column18
(25 cm x 0.46 cm). Solvent A was 0.1% TFA; solvent B 
was 0.1% TFA in 60% acetonitrile. The gradient used 
is indicated by the dotted line. The flow rate was 
1 ml/min.
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Fig. 3.2. Standard curve for the quantification of M-AKH by HPLC.
Peak areas were integrated by a Gilson Model 620 Data 
Master during calibration analyses as illustrated in 
Fig. 3.1b.
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Fig. 3.3. Separation of labelled [ Tyr ] M-AKH from free Na I. The
iodination mixture was loaded onto a primed C SepPak18
cartridge, washed with 0.25 M phosphate buffer and 
eluted by a graded series of methanol solutions 
(3 x 600 yl each). A 10 yl aliquot from each fraction 
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Fig. 3.4. RIA assessment of the antibody titre in serum from rabbit 
158 following the terminal bleed. 50 Hi of serum (1/600) 
was incubated overnight with 50 Ml of buffer and 50 Hi of 
labelled peptide (approximately 9,000 c.p.m.). The 
incubation was terminated by the addition of 500 Hi of 
charcoal solution. The mixture was incubated at 4°C for 
7-8 min and then centrifuged at 4,500 r.p.m. for 15 min. 
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Fig. 3.5. Competition assay to determine the specificity of the
RIA. Unlabelled peptides were incubated with serum (at a 
final concentration of 1/1800) and labelled peptide 
(9,000 cpm). The peptides assayed were M-AKH (#),
AKH-I (O), AKH-I I (L) (□), M-II (<g> ) , HTF-II (A),
LK-II (A) and LK-VI (Q).
Table 3.1. Quantification of M-AKH in adult and larval tissues from
Manduca by RIA. Tissues were homogenised in methanol :
water : acetic acid (90:9:1) and centrifuged at
12,000 r.p.m. for 5 min. The supernatants were dried
down and resuspended in 1 %  TFA. The samples were then
lipid extracted with ethyl acetate and processed through
a C1Q SepPak cartridge. This material was dried down,
18
resuspended in RIA buffer and assayed. Values represent 
mean ± standard error (SE) for n samples.
Tissue M-AKH Content (ng/tissue) n
Adult CC 21.00 ± 0.88 5
Adult Brain 0.67 ± 0.08 4
Adult Nerve Cord 0.08 ± 0.01 4
Larval CC 2.20 ± 0.14 4
Larval Brain 0.06 ± 0.02 5
Larval Nerve Cord 0.11 ± 0.05 5
Fig. 3.6. Identification of M-AKH immunoreactive material.
a) HPLC analysis of Manduca adult CC extract (1 pair 
equivalent). The chromatographic conditions were the 
same as those described in Fig. 3.1 except for the 
gradient, indicated by the dotted line. Fractions were 
collected by a Gilson Model 201/202 fraction collector 
at 1 min intervals. The peak eluting at 25.5 min is 
identified as M-AKH on the basis of the retention time 
of synthetic M-AKH.
b) RIA of aliquots from the fractions collected in a) and 
from HPLC of larval CC. Aliquots represented 
approximately 0.05 adult CC pair equivalents per tube 
and 0.4 larval CC pair equivalents. Each aliquot was 
lyophilised and then resuspended in 50 pi of RIA 
buffer for the assay. Aliquots outside the region of 
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Fig. 3.7. Determination of M-AKH immunoreactivity in haemolymph
of starved and fed larvae. Day 3, fifth instar larvae
were bled at the times indicated after the start of
the experiment. Haemolymph was frozen, boiled and then
centrifuged at 2,000 r.p.m. for 5 min and the
supernatant removed and processed through a C._ SepPak
18
cartridge. The eluted material was lyophilised and 
resuspended in RIA buffer (50 V I )  and assayed. Points 
and vertical bars for starved larvae (#) and fed 
larvae (O) represent means ± SE (n = 5 for each 
point).















CHAPTER 4. BIOLOGICAL ACTIVITIES OF M-AKH
INTRODUCTION
The corpora cardiaca (CC) of Manduca have been shown to contain 
a factor (or factors) which causes hyperlipaemia when injected into 
adult moths (Beenakkers et al., 1978) and fat body glycogen 
phosphorylase activation when injected into larvae (Ziegler, 1979). 
The latter activity is thought to be important in the regulation of 
carbohydrate metabolism during the period of starvation which 
occurs around the larval moult (Siegert and Ziegler, 1983). In 
adult Manduca the CC factor regulates lipid metabolism during 
flight, but does not appear to regulate carbohydrate metabolism 
during flight despite its ability to activate adult fat body 
phosphorylase (Ziegler and Schulz, 1986a, 1986b).
A peptide that causes hyperlipaemia in moths and phosphorylase 
activation in larvae when injected, has been isolated and sequenced 
from the CC of adult Manduca (Ziegler et al., 1984; 1985).
Initially it was suggested that this peptide (M-AKH) was different 
to the larval glycogen phosphorylase activating hormone (GPAH) 
(Ziegler et al., 1986), however recent evidence from the bioassay 
of CC extracts has led Ziegler et al. (1987) to conclude that M-AKH 
is in fact identical to GPAH.
In am attempt to clarify the physiological roles of M-AKH in 
larval and adult Manduca, I have quantitatively assayed synthetic 
M-AKH for adipokinetic activity in moths and glycogen phosphorylase 
activation in larvae, comparing these activities with data from CC
extract bioassays. Synthetic M-AKH was also assayed for cardio- 
activity in larval Manduca.
MATERIALS AND METHODS 
Experimental Animals
Manduca sexta were reared in a colony at the University of Bath 
as described in Chapter 3. Adipokinetic assays were performed with 
day 1 adult moths of both sexes, starved overnight before the assay 
to minimize the differences in the metabolic fuel stores between 
individual moths. Phosphorylase assays were performed with day 2, 
fifth instar larvae. Day 3, fifth instar larvae were used for the 
determination of the haemolymph titre of M-AKH and for the 
cardioactivity assay.
Assay Reagents
Synthetic M-AKH test solutions were prepared by aqueous 
dilution from a stock solution of 0.1 mg/ml in 10% acetonitrile. CC 
extracts were prepared, as reported in Chapter 3, by a modification 
of the method reported by Jaffe et al. (1986). Phosphoglucomutase 
and glucose 6-phosphate dehydrogenase were purchased from 
Boehringer-Mannheim, Lewes, U.K. All other reagents were of 
analytical grade and were purchased from Sigma.
Oyster glycogen (from Sigma) was treated with charcoal to 
remove traces of AMP. 3 g of glycogen was stirred with 2 g of 
activated charcoal in distilled water for 1 h. The glycogen 
solution was separated from the charcoal by centrifugation at
10,000 r.p.m. for 15 min in an MSE High Speed 18 centrifuge. The
supernatant (glycogen solution) was filtered through a Whatman GF-D 
filter and a Whatman sterile membrane filter (0.45 vim). An equal 
volume of 95% ethanol was added to the filtrate to precipitate the 
glycogen which was then recovered by filtration using Whatman No. 5 
filter paper. The precipitated glycogen was washed with ethanol and 
ether and stored in a desiccator at 4°C.
Adipokinetic Assay
Haemolymph was collected immediately before or 100 min after 
injection of 10 \il of the test solution into the abdomen of the 
moth. A 5 nl sample of haemolymph was collected in a pyrex 
micropipette by puncturing the dorsal aorta in the abdominal 
region. The sample was transferred to 1 ml of concentrated 
sulphuric acid in a chloroform/methanol washed test-tube. The 
samples were placed in a boiling water bath for 10 min and then 
cooled in cold water. A 100 yl aliquot was removed from each 
sample, added to 1 ml of vanillin reagent (13 mM vanillin in 80% 
concentrated phosphoric acid), vortex mixed immediately and left to 
stand at room temperature for 30 min. The absorbance of each sample 
was then measured at 546 nm in a Philips Pye Unicam 8650 spectro­
photometer. A calibration curve was prepared using standards 
prepared from a stock solution of cholesterol in methanol (0.8 
mg/ml, since 0.8 mg of cholesterol has an absorbance equivalent to
1.0 mg of total lipid - Barnes and Blackstock, 1973).
Glycogen Phosphorylase Assay
Larvae were lightly anaesthetised with 00^ prior to injection
with 10 yl of the test solution. Each larva was replaced on 
artificial diet for 10 min before the fat body was rapidly removed. 
The excised tissue was rinsed quickly in Manduca saline (40 mM KC1, 
4 mM NaCl, 18 mM MgCl2> 3 mM CaCl2, 1.5 mM Na2HP04, 1.5 M NaH2P04, 
193 mM sucrose, pH 6.5), lightly blotted on filter paper and 
homogenised in 1 ml of buffer (50 mM triethanolamine acetate, 5 mM 
Na2EDTA, 20 mM NaF, 1 mM phenylthiourea (PTU), pH 7.0). The 
excision-homogenization took less than 1 min. Homogenates were 
stored on ice prior to centrifugation at 11,600 g for 15 min at 4°C 
in an MSE MicroCentaur. The infranatant was withdrawn and used for 
the assay.
Phosphorylase was assayed in the direction of glycogen 
degradation at 25°C by a coupled enzyme assay which followed the 
reduction of NADP (Ziegler et al., 1979). The assay mixture for the 
measurement of phosphorylase a contained the following components 
in a final volume of 1.0 ml: 42 mM triethanolamine acetate, 5.5 mM 
imidazole, 2 mM Na2EDTA, 1.4 mM dithiothreitol, 80 mM KH2P04,
5.1 mM magnesium acetate, 0.6 mM NADP, 0.002% BSA, 10 mg/ml 
glycogen, 1.24 yM glucose 1,6-diphosphate, 0.98 units of 
phosphoglucomutase, 0.43 units of glucose 6-phosphate dehydrogenase 
and 50 yl of the phosphorylase preparation at pH 7.0. The mixture 
was placed in a cuvette and the absorbance monitored continuously 
at 340 nm in a Cecil CE 373 spectrophotometer for 15 min. The 
change in absorbance due to the reduction of NADP was recorded with 
a Rikadenki chart recorder. To measure the total phosphorylase 
activity within the sample 50 yl of 40 mM AMP was added to the 
mixture and the absorbance was monitored for a further 15 min. The
gradients displayed on the chart recorder were measured by hand and 
used to calculate the percentage of active phosphorylase 
(phosphorylase a) within the sample.
Cardioactivity Assay
Cardioactivity was assayed using a semi-isolated larval heart 
preparation developed by Platt and Reynolds (1985). The heart was 
left to stabilize for a few hours while perfused with Manduca 
saline. A 750 pmol dose of M-AKH (50 yl of 15 yM peptide) was 
applied onto the preparation with a syringe and the effect on 
cardioactivity was monitored. The contraction of the heart was 
monitored by the deflection of a small hook, inserted under the 
heart which was connected via a thread to an almost isotonic 
movement transducer. The transducer's output was displayed on a 
Servogor 120 chart recorder. A 5 pmol dose of serotonin (50 yl of 
0.1 yM 5-HT) was used to demonstrate the responsiveness of the 
heart to a known cardioaccelerator.
RESULTS
The activity of synthetic M-AKH was determined by its effect on 
haemolymph lipid levels, fat body glycogen phosphorylase activity 
and on the beating of the heart. Synthetic M-AKH elicited lipid 
mobilisation in adult moths with a maximal increase of 33 mg/ml in 
response to the injection of 2 pmol of peptide (Fig. 4.1). The dose 
required to produce a 50% maximal response may be estimated to be 
approximately 0.3 pmol of M-AKH.
The adipokinetic activity of adult CC extracts was also 
investigated (Fig. 4.2). A partial dose-response curve was obtained 
which indicated a maximal increase of 30 mg/ml in response to a 
dose of 0.1 CC equivalents and a 50% maximal response to 0.005 CC 
equivalents (Fig. 4.2a). The dose-response curve is shown in 
comparison with a theoretical dose-response curve for CC extract 
which was replotted from the synthetic M-AKH dose-response curve by 
assuming a titre of 21 pmol/CC as reported in Chapter 3. At low 
doses (less than 0.01 CC equivalents) the adipokinetic response to 
CC extract was greater than that predicted from the theoretical 
curve. However at doses above 0.1 CC equivalents the observed 
response resembled the predicted response to higher doses of CC 
extract. If the curves are replotted to show the response in terms 
of the percentage of the maximal response in each experiment (Fig. 
4.2b), the curve for the CC extract appears to be displaced to the 
left of the curve derived from the synthetic M-AKH data. This 
suggests that the M-AKH content of the adult CC is insufficient to 
account for all of the adipokinetic activity in the CC and may 
therefore indicate the activity of a second adipokinetic factor 
from the CC.
Larval fat body glycogen phosphorylase was maximally activated 
(65% phosphorylase a) following the injection of a 2 pmol dose of 
synthetic M-AKH (Fig. 4.3). 50% maximal activation would be 
elicited by a dose of approximately 0.06 pmol of M-AKH. The larval 
phosphorylase response therefore appears to be more sensitive to 
M-AKH than the adult adipokinetic response.
M-AKH was not cardioactive when assayed on a semi-isolated 
larval heart (Fig. 4.4) No change was observed in the amplitude or 
rate of the larval heartbeat when a very large dose (750 pmol) of 
M-AKH was applied. The responsiveness of the preparation was 
demonstrated by the application of serotonin (5 pmol) which
stimulated both the rate and amplitude of contraction as expected.
DISCUSSION
The discovery of sin adipokinetic factor in the CC of Manduca 
which appeared to be chemically different to locust AKH, supported 
the hypothesis that there was more than one adipokinetic hormone in
insects (Beenakkers et al., 1978). Subsequently a number of
AKH-like peptides were isolated from a variety of insect species. 
Among these were two additional peptides from locusts (Siegert 
et al., 1985) and two peptides from the cockroach Periplaneta 
americana (Witten et al., 1984). Recently, two AKH/RPCH family 
peptides have been sequenced from the grasshopper Romalea 
microptera (Gade et al., 1988). The reason for the existence of two 
peptides with overlapping biological activities in the same species 
is unknown.
Ziegler and Gade (1984) were unable to separate the glycogen 
phosphorylase activating hormone (GPAH) from the adipokinetic 
hormone (M-AKH). in adult Manduca CC by conventional chromatographic 
techniques. Subsequently, Ziegler e_t al. (1986) separated two 
peptides from larval CC by RP-HPLC. They con eluded that M-AKH and 
GPAH were different peptides with overlapping biological 
activities. However amino acid analysis and bioassay data have
since been reported to demonstrate the identity of both hormones 
with the nonapeptide M-AKH (Ziegler et al., 1987).
In this study synthetic M-AKH was found to possess adipokinetic 
and phosphorylase activating activity in adult and larval Manduca, 
respectively. The ability of CC extract or synthetic M-AKH to 
activate adult fat body glycogen phosphorylase was not tested.
The most economical
hypothesis would seem to be that M-AKH regulates both processes 
in vivo. However a comparison of the dose-response curve for 
adipokinetic activity in response to adult CC extracts with a 
theoretical dose-response curve suggests that M-AKH may not be the 
only adipokinetic factor within the adult CC. The maximum response 
to injected CC extract appeared to be the same as that elicited by 
M-AKH, but at lower doses the activity of the CC extract was not 
fully accounted for by the M-AKH content alone.
A related insect, the corn earworm moth, Heliothis zea 
possesses two AKH/RPCH family peptides. One of these (H-AKH-I) is 
identical to M-AKH, whilst a second peptide (H-AKH-II) with less 
adjpokinetic activity, has recently been sequenced from Heliothis 
CC (pGlu-Leu-Thr-Phe-Ser-Ser-Gly-Trp-Gly-AsnNH^, Jaffe et al. , 
1988b). This discovery would appear to strengthen the hypothesis 
that there is a second peptide in Manduca CC, but the isolation of 
such a peptide remains a task for the future.
RIA analysis of CC extracts following HPLC separation indicated 
a second peak of immunoreactive material distinct from that due to 
M-AKH (see Chapter 3). Although it was not possible to obtain a 
sample of the second Heliothis AKH/RPCH peptide for comparison, it
would seem unlikely that the M-AKH immunoreactive material eluting 
later than M-AKH is the same peptide. In the HPLC system used by 
Jaffe et al. (1988b), the second Heliothis peptide eluted at a 
lower concentration of acetonitrile than M-AKH, unlike the M-AKH 
immunoreactive material reported here. In any case, on the basis of 
its C-terminal sequence the Heliothis peptide would not be expected 
to show a significant degree of cross-reactivity in the M-AKH RIA 
(see Chapter 3). The adipokinetic activity of the late-eluting 
M-AKH immunoreactive material has not yet been determined so it 
cannot be concluded that it is responsible for the additional 
bioactivity in adult CC extracts.
The unknown immunoreactive material was also present in larval 
Manduca CC extracts yet the adipokinetic response to larval CC 
extracts reported by Ziegler et al. (1987) was consistent with the 
identification of M-AKH as the only adipokinetic factor within 
larval CC. This again suggests that the putative second AKH/RPCH 
peptide in adult Manduca CC is probably not the same as the 
immunoreactive material reported in Chapter 3.
A comparison of the glycogen phosphorylase activation dose- 
response curve for synthetic M-AKH with the previously reported 
activities of larval and adult CC extracts (Ziegler et al., 1988; 
Ziegler, 1979) supports the hypothesis that M-AKH is identical to 
GPAH. The reported response of larval fat body glycogen 
phosphorylase to injected CC extracts (a 50% maximal response to 
0.003 adult CC equivalents or 0.03 larval CC equivalents) was very 
consistent with the activity of synthetic M-AKH reported here (a 
50% maximal response to 0.06 pmol of M-AKH) and the CC titres
in Chapter 3.
Starvation is known to cause the release of GPAH from the 
larval CC leading to fat body phosphorylase activation (Siegert and 
Ziegler, 1983). Using an M-AKH specific RIA I have shown that M-AKH 
is released into the haemolymph within the first hour of starvation 
(see Chapter 3). On this basis the phosphorylase response would 
also be expected to peak at about 1 h since phosphorylase 
activation is known to be rapid (Ziegler, 1979), however Siegert 
(1987) reported a peak of phosphorylase activity between 2 h and 
3 h after the onset of starvation. The discrepancy between the data 
presented in Chapter 3 and those of Siegert (1987) may be due to 
differences in the laboratory cultures of Manduca used, 
particularly in relation to the quality of the artificial diet. 
Further work is required to confirm the identity of the immuno­
reactive material in larval haemolymph and to obtain a direct 
comparison of the haemolymph M-AKH titre and phosphorylase activity 
in the same insect. Nevertheless, the bioassay and RIA data support 
the hypothesis that M-AKH and GPAH are identical.
AKH/RPCH peptides can also affect the activity of muscles and 
the two cockroach peptides M-I and M-II were originally isolated on 
the basis of their cardioactivity in the cockroach (Scarborough 
et al., 1984) and their myotropic activity in locust leg muscle 
(O'Shea et al., 1984). Therefore it seemed appropriate to test 
synthetic M-AKH for myotropic activity in Manduca. The assay used 
was the semi-isolated larval heart described by Platt and Reynolds
(1985). M-AKH failed to affect either the rate or amplitude of the 
heartbeat, even when applied in large amounts. Platt and Reynolds
(1986) had previously observed that AKH-I also lacked cardio­
activity in Manduca. While this assay indicates that M-AKH is not 
involved in the control of the heartbeat in Manduca, it remains 
possible that M-AKH may affect other muscles.
AKH-I has been shown to inhibit protein synthesis in the locust 
fat body (Carlisle and Loughton, 1986). The effect of synthetic 
M-AKH and CC extracts on protein synthesis in Manduca fat body has 
been investigated in our laboratory. Neither synthetic M-AKH (at a 
dose of 20 nM iji vitro or 10-50 nM in vivo) nor CC extract (1 CC 
equivalent per fat body incubation or per insect) caused a 
significant change in fat body protein synthesis (Prosser, 1987). 
The relevance of this finding remains unclear as the physiological 
explanation for the effect of AKH-I on protein synthesis in locusts 



























Fig. 4.1. Adipokinetic assay of synthetic M-AKH in adult Manduca, 
Haemolymph samples (5 yl) were collected immediately 
before and 100 min after injection of the peptide. 
Haemolymph lipid levels were determined by a 
sulphophosphovanillin method. Points and vertical bars 
represent the mean ± S.E. for the number of samples 
indicated above each point.
Fig. 4.2. Adipokinetic assay of adult CC extract. Method as 
described in Fig. 4.1.
a) Absolute increase in haemolymph lipids is shown in 
comparison with the theoretical curve (dotted line) 
derived from the dose-response curve in Fig. 4.1 and 
the M-AKH content of adult CC determined by RIA
(21 pmol/CC). Points and vertical bars for the 
observed response represent the means ± S.E. for the 
number of samples indicated above each point.
b) Data from a) expressed as a relative response 
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Fig. 4.3. Fat body glycogen phosphorylase assay of synthetic
M-AKH. Day 2, fifth instar larvae were injected with the 
test dose of peptide. After 10 min the fat body was 
rapidly removed and homogenised in buffer (50 mM TEA,
5 mM Na^EDTA, 20 mM NaF, 1 mM PTU, pH 7.0) centrifuged 
at 11,000 g for 15 min and the infranatant withdrawn for 
the assay of glycogen phosphorylase in the direction of 
glycogen degradation as described by Ziegler et al. 
(1979). Points and vertical bars represent means ± S.E. 





Fig. 4.4. Cardioactivity of synthetic M-AKH (top trace) compared
with serotonin (bottom trace) assayed on a semi-isolated 
larval Manduca heart at the doses indicated.
CHAPTER 5. PHARMACOLOGY OF THE ADIPOKINETIC RESPONSE TO M-AKH
INTRODUCTION
The characteristics of a peptide receptor may be investigated 
by assaying synthetic or natural peptides which are structurally 
related to the native peptide. Shortly after the sequence of locust 
AKH-I was determined (Stone et al., 1976), the structure-activity 
relationships of a number of synthetic analogues of varied length 
and sequence were investigated in the locust (Stone £t al., 1978).
The discovery of a family of insect peptides related to locust 
AKH-I and the prawn red pigment concentrating hormone (RPCH) has 
provided an additional impetus for the study of structure-activity 
relationships. Naturally occurring AKH/RPCH family peptides have 
been assayed for adipokinetic activity in the locust (Goldsworthy 
et al., 1986a, 1986b) and hypertrehalosaemic activity in the 
cockroach (Gade, 1986). These studies have provided information on 
the amino acid residues and sequences that are required for 
biological activity in the recipient insects (Goldsworthy and 
Wheeler, 1986).
I have investigated the adipokinetic activity of AKH/RPCH 
family peptides in adult Manduca. Synthetic AKH/RPCH peptides were 
assayed separately and in competition with the native peptide, 
M-AKH. The results will be discussed in relation to the 
characteristics of the M-AKH receptor of Manduca fat body.
MATERIALS AND METHODS 
Sources of Peptides
M-AKH was synthesised as described in Chapter 2. Locust AKH-I 
was purchased from Peninsula Laboratories, St. Helens, U.K. The 
other synthetic peptides were gifts from the following sources: 
Prawn red-pigment concentrating hormone (RPCH) from Professor G.J. 
Goldsworthy, Birkbeck College, London, U.K.; Locust adipokinetic 
hormones II (AKH-II(S) and AKH-II(L)) from Professor W. Mordue, 
University of Aberdeen, U.K.; Cockroach myoactive factors (M-I and 
M-II) from Professor M. O'Shea, University of Geneva, Switzerland; 
Carausius hypertrehalosaemic factor II (HTF-II), Nauphoeta 
hypertrehalosa:emic hormone (HTH) and the Romalea peptides (Rol and 
Roll) from Dr. G. Gade, University of Dusseldorf, F.R.G. Stock 
solutions were quantified by HPLC.
Adipokinetic Assay
A 50 pmol dose of each peptide was assayed for adipokinetic 
activity by the sulphophosphovanillin method described in Chapter 
4. Those peptides which displayed significant activity at this dose 
were assayed at lower doses to obtain a dose-response curve for 
each peptide.
For the competition assays test solutions were prepared so that 
15 yl of solution contained 2 pmol of M-AKH and 20 pmol of another 
AKH/RPCH peptide. This solution was assayed for adipokinetic 
activity as described previously.
RESULTS
Apart from M-AKH itself, only five of the peptides tested at a 
supramaximal dose of 50 pmol stimulated a significant increase in 
haemolymph lipid levels (Table 5.1). If the response to M-AKH is 
taken as defining the maximal adipokinetic response then only M-AKH 
is a full agonist. Three other peptides were found to be partial 
agonists. HTF-II from the stick insect, Carausius morosus caused a 
50% maximal response at approximately 0.3 pmol as did the native 
peptide, however the maximum increase in lipids following HTF-II 
injection was only 22.5 mg/ml (68% of the maximal response to 
M-AKH, Fig. 5.1). Locust AKH-I stimulated a maximum increase of 21 
mg/ml (64% of the maximal response to M-AKH). In this case a 50% 
maximal response was elicited by 2-3 pmol of peptide (Fig. 5.2).
The myoactive and hypertrehalosaemic peptide M-II from the 
cockroach Periplaneta americana elicited a maximum increase of 18 
mg/ml (55% of the maximal response to M-AKH) and the dose required 
for a 50% maximal response was approximately 10 pmol (Fig. 5.3).
HTH from the cockroach Nauphoeta cinerea and RPCH from prawns both 
elicited a small but significant increase in haemolymph lipids at a 
dose of 50 pmol (8.8 and 9.0 mg/ml, respectively) however the 
responses to 10 pmol of HTH (7.1 ± 2.4 mg/ml, n = 8) and to 20 pmol 
of RPCH (5.7 ± 2.3 mg/ml, n = 6) were not significantly different 
from the control. All the other peptides tested failed to elevate 
haemolymph lipid levels significantly even at a dose of 50 pmol per 
insect.
A further series of assays investigated the ability of AKH/RPCH 
peptides to interact with M-AKH when injected into adult moths
(Table 5.2). The only peptides to produce a significant change in 
the adipokinetic response when co-injected in ten-fold excess with 
M-AKH were AKH-I and HTF-II. In both cases the response to the 
peptide co-injection (24.7 mg/ml for AKH-I and 22.0 mg/ml for 
HTF-II) was significantly lower than the response to M-AKH alone 
(32.3 mg/ml). In fact the co-injection responses were similar to 
those elicited by AKH-I and HTF-II when injected alone (22.6 mg/ml 
and 2 0 . 8  mg/ml respectively).
DISCUSSION
Studies on the pharmacology of the adipokinetic response in 
Locusta indicate that several members of the AKH/RPCH family can 
stimulate the maximal response although higher doses of these 
peptides are always required than is the case for AKH-I 
(Goldsworthy et al. , 1986a, 1986b). Next to AKH-I, the most 
effective agonist in Locusta was the stick insect peptide HTF-II 
which elicited a maximal response at a dose of 8  pmol, compared 
with 2 pmol of AKH-I. The cockroach peptides M-I and M-II and the 
prawn peptide RPCH had virtually identical activity, stimulating 
the maximal response at a dose of approximately 20 pmol. HPLC- 
purified AKH-II(S) and AKH-II(L) failed to elicit a maximal 
response in Locusta even at high doses, however recent studies 
suggest that this may have been due to losses of peptide during the 
extraction procedure. Synthetic AKH-II(S) elicited a maximal 
response in Locusta at a dose of approximately 5 pmol but the 
maximum response to synthetic AKH-II(L) was only 50% of the maximal 
response (Goldsworthy and Wheeler, 1986). M-AKH also elicited a
truncated response in Locusta (45% of the maximal response, Wheeler 
et al., 1988).
The results from these studies and the earlier work on 
synthetic AKH analogues (Stone et al., 1978; Hardy and Sheppard, 
1983) have been interpreted in terms of the sequence requirements 
of the locust AKH receptor. Stone et al. (1978) found that a 
minimum of eight amino acid residues was required for adipokinetic 
activity and that the N-terminal L-pyroglutamate residue was 
essential for full activity. The importance of the C-terminal 
sequence was indicated by the low activity of [jhr^, GlyNH^^^jAKH-I 
in which the residues at positions 9 and 10 in AKH-I were 
exchanged.
Using a predictive model for the secondary structure of
proteins Mordue and Stone (1978) proposed that AKH-I might possess
a 8 -turn at residues 6  to 8 . Hardy and Sheppard (1983) demonstrated
a marked reduction in the activity of [ 3,4-DehydroPro^] AKH-I
6 ~compared with AKH-I indicating the importance of the [ Pro j 
residue. The studies of Goldsworthy et al. (1986a, 1986b) suggested
g
that [Pro ]-containing AKH/RPCH peptides could act as full agonists
g
whereas the peptides which lack [ Pro j always gave a truncated 
response. This was thought to indicate differences in the secondary 
structure of the two groups of peptides. Recent studies using 
circular dichroism spectroscopy have investigated the probability 
of a B-turn being present in AKH-I and related peptides (G.J. 
Goldsworthy, personal communication). None of the AKH/RPCH peptides 
appear to possess a |3-turn in aqueous solutions however in the 
presence of SDS-micelles (which are thought to mimic the conditions
which prevail in the environment of the receptor), all the
g
[Pro ]-containing peptides appear to form a B-turn whereas the
g
non-[Pro ] containing peptides (including M-AKH and AKH-II(S)) do 
not. The activity of synthetic AKH-II(S) in Locusta cannot be 
explained in terms of a 0-turn but it is thought that AKH-I forms a 
type I 0-turn when bound to the locust fat body receptor. Gade
g
(1986) concluded that [Pro ] is also important to hypertrehalo- 
saemia in the cockroach Periplaneta americana possibly indicating a 
requirement for a 0 -turn by the cockroach fat body receptor.
The study in Manduca reported here did not investigate the 
requirement for an N-terminal pyroglutamate residue, however the 
inactivity of [Tyr^ ] M-AKH reported in Chapter 2 indicates that this 
residue is probably essential. The importance of other residues 
within the sequence of M-AKH may be inferred by comparison with 
other AKH/RPCH peptides. The pharmacology of the adipokinetic 
response in Manduca may be quite different to that of Locusta as 
the native peptide, M-AKH, does not possess a proline residue and 
is not thought to adopt a 0 -turn structure.
M-AKH is unique among the known AKH/RPCH peptides in possessing 
a serine residue at position 6 . This may be essential for full 
adipokinetic activity as none of the other peptides tested elicited 
the maximal response even at high doses (up to 50 pmol per insect). 
AKH-I and HTF-II both stimulated a 65-70% maximal response, though 
HTF-II was notably more active than AKH-I at low doses. The only 
sequence difference between these two peptides is the replacement 
of [ Asn^j in AKH-I by [Thr^j in HTF-II, the latter peptide thus 
possessing considerable homology with M-AKH at the N-terminal
region. M-II is identical to HTF-II apart from the absence of
residues 9 and 10 at the C-terminal and shows a maximal response of
55% of the full adipokinetic response. The dose response curve for
M-II is quite different to that for HTF-II, the latter peptide
causing an.jadipokinetic response at doses some fifty times less
than in the case of M-II. This is presumably due to the absence of 
9 10the [Gly ] and [Thr ] residues in M-II. M-AKH has only 9 residues
g
so it would seem that [ Gly ] is important for adipokinetic activity 
while [ Thr^ ] is not. The Nauphoeta peptide, HTH, and RPCH (only 
active at a dose of 50 pmol) clearly possess very poor adipokinetic 
activity in Manduca, being at least 500 times less potent than
M-AKH. The inactivity of the Romalea peptide Rol which differs from
2 2AKH-I by possessing a [ Val ] residue rather than [Leu ] indicates a
requirement for leucine rather than valine at position 2 .
A preliminary assessment of the sequence requirements of the
Manduca receptor for M-AKH therefore indicates an absolute
1 2 ,  3requirement for [ pGlu ] and [Leu] for activity. [Thr ] appears to
be important for activity at low doses and the importance of [ Phe4]
is suggested by the relative inactivity of the analogue
[Iodo-Phe^]M-AKH reported in Chapter 2. All the active peptides
possess a [Thr J residue however my results do not demonstrate
5
activity specifically due to the presence of [Thr ] in a peptide 
since no peptide differed from M-AKH at this residue alone. 
Interestingly, the cockroach peptide leucokinin II, which has the
same C-terminal tetrapeptide sequence as M-AKH, did not show
significant adipokinetic activity when assayed at a dose of 50 pmol 
(increase in haemolymph lipid = 4.9 ± 1.3 mg/ml, n = 5). This
confirms the importance of the N-terminal sequence. The serine 
residues at positions 6  and 7 are unique to M-AKH and may be vital 
for full adipokinetic activity. All the known members of the 
AKH/RPCH family possess a tryptophan residue at position 8  and its 
conservation is assumed to indicate its requirement for activity. A 
comparison of the dose response curves for HTF-II and M-II suggests 
that the glycine amide at position 9 (the C-terminal) may be 
required for activity at low doses. The partial agonists at the
g
M-AKH receptor possess a [ Pro ] residue and probably form a 3 -turn 
but it is thought to be unlikely that M-AKH forms such a turn. The 
present results do not permit any further comment on the secondary 
structure of M-AKH at the fat body receptor.
Both cockroaches and locusts have been shown to possess two 
AKH/RPCH peptides with overlapping biological activities. It is not 
known whether these peptides are active at the same or separate 
receptors. In the locust preliminary evidence suggested that two 
receptors may be present. Locusts were injected with a supramaximal 
dose of AKH-II, assumed to be sufficient to saturate the 
appropriate receptors and then a dose of AKH-I was injected. An 
increase in the adipokinetic response following the injection of 
AKH-I was observed and interpreted as evidence for a separate 
population of AKH-I receptors which were available for binding 
despite the presence of AKH-II in excess (G.J. Goldsworthy, 
personal communication).
In an attempt to investigate the possibility that more than one 
AKH receptor may be present in Manduca, a series of competition 
assays were performed with a 2 pmol dose of M-AKH (sufficient to
elicit the maximal response), co-injected with a 2 0  pmol dose of 
another peptide. In most cases there was no evidence of any 
competition and the full response was observed, however coinjection 
of HTF-II or AKH-I resulted in a significant reduction of the 
adipokinetic response. This antagonism is most economically 
explained as being due to competitive binding by the excess peptide 
at a single M-AKH receptor resulting in a response which more 
closely resembles that elicited by 20 pmol of HTF-II or AKH-I alone 
rather than the response to 2 pmol of M-AKH.
Since the majority of the peptides tested showed no ability to 
mobilize lipids when injected alone, it is not surprising that they 
showed no ability to antagonise the activity of M-AKH. However the 
cockroach peptide M-II which shows appreciable activity on its own, 
did not appear to affect the activity of M-AKH when co-injected 
with the native peptide. The affinity of the AKH-receptor for M-II 
is some fifty-fold less than for HTF-II so it may be that the 
competing concentration of M-II was insufficient to demonstrate any 
antagonistic effect. Unfortunately it was not possible to perform 
competition experiments with larger doses of M-II. The failure of 
M-II to give an additive effect with M-AKH suggests that like 
HTF-II and AKH-I it does not interact with a second receptor type 
but with the same receptor that accepts M-AKH itself.
In this model, the failure of the three partial agonists to 
produce a full adipokinetic response is due to their failure to 
interact with the receptor in qualitatively the same way as does 
M-AKH. Further studies are required to explore this model more 
fully, for example the use of synthetic M-AKH analogues that
closely resemble M-AKH, especially at positions 6  and 7, would be 
particularly helpful.
Table 5.1. Adipokinetic activity of AKH/RPCH peptides in adult Manduca
Peptide Sequence Maximum Response
M-AKH pGlu-Leu-Thr-Phe-Thr-Ser-Ser-Trp-GlyNH^ 32.4 ± 2 .2 **
HTF-II pGlu-Leu-Thr-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH^ 20.5 ± 1 .8 **
M-II pGlu-Leu-Thr-Phe-Thr-Pro-Asn-TrpNH^ 18.0 ± 1.3**
AKH-I pGlu-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH2 20.7 ± 1.7**
Rol pGlu-Val-Asn-Phe-Thr-Pro-Asn-Trp-Gly-ThrNH2 4.7 ± 1 . 2
HTH pGlu-Val-Asn-Phe-Ser-Pro-Gly-Trp-Gly-ThrNH2 8 . 8 ± 1 .8 *
M-I pGlu-Val-Asn-Phe-Ser-Pro-Asn-TrpNH2 2.5 ± 1 . 1
Roll pGlu-Val-Asn-Phe-Ser-Thr-Gly-TrpNH2 4.0 ± 2 . 2
AKH-II(S) pGlu-Leu-Asn-Phe-Ser-Thr-Gly-TrpNH2 1 . 2 ± 1 . 1
AKH-II(L) pGlu-Leu-Asn-Phe-Ser-Ala-Gly-TrpNH2 2.5 ± 2.3
RPCH pGlu-Leu-Asn-Phe-Ser-Pro-Gly-TrpNH2 9.0 ± 1 .1 *
Maximum response in mg/ml to 50 pmol of peptide. Values represent mean ± S.E. (where h > 6 ). 
Asterisks indicate which responses were significantly different from the control according to 



































Fig. 5.1. Adipokinetic assay of synthetic HTF-II in adult 
Manduca. Dotted line indicates the dose-response 
curve for M-AKH. Points and bars represent 


































Fig. 5.2. Adipokinetic assay of synthetic AKH-I in adult 




























Fig. 5.3. Adipokinetic assay of synthetic M-II in adult 




Table 5.2. The adipokinetic effect of 20 pmol of AKH/RPCH peptides alone and co-injected 
with 2 pmol of M-AKH.
Peptide Adipokinetic Response (mg/ml)
20 pmol Test Peptide 20 pmol Test Peptide + 2 pmol M-AKH
Control
(no test peptide) 4.7 + 1.9 (5) 32.3 + 1.5 (14)
HTF-II 2 0 . 8 + 1.5 (6 ) 2 2 . 0 + 2 .0 * (7)
M-II 18.8 + 3.1 (9) 33.8 + 1.7 (9)
AKH-I 2 2 . 6 + 1.9 (5) 24.7 + 3.0* (6 )
Rol 5.5 + 3.9 (5) 30.5 + 2.4 (7)
HTH 8 . 2 + 2 . 2 (5) 34.2 + 2.3 (5)
M-I 7.1 + 1 . 8 (5) 30.8 2 . 1 (5)
Roll 2 . 6 + 2.7 (5) 31.1 + 2 . 2 (5)
AKH-II(S) 4.7 + 2.4 (5) 32.6 + 3.6 (5)
AKH-II(L) 5.3 + 3.5 (5) 34.8 + 2 . 6 (5)
RPCH 5.7 + 2.3 (6 ) 28.8 + 1.5 (5)
Control injection was 10 yl of 10% acetonitrile. Values indicate the mean response ± S.E. 
for the number of replicates indicated in parentheses.
* indicates a significant difference between the co-injected response and the response to 
M-AKH alone (t-test, p > 0.01).
CHAPTER 6. ENZYMATIC DEGRADATION OF M-AKH BY HAEMOLYMPH
INTRODUCTION
Neuropeptide inactivation has been extensively investigated in 
vertebrates during the last ten years. Although inactivation by 
non-enzymatic processes, such as diffusion,(re-uptake and 
peptide-receptor internalisation cannot be discounted, the majority 
of studies have concentrated on the hydrolysis of neuropeptides by 
membrane-bound and soluble peptidases (Bauer, 1985; McKelvy and 
Blumberg, 1986). These studies have shown that peptidase 
specificity is usually determined by the localisation of the enzyme 
rather than the specificity of the enzyme for its substrate (Kenny, 
1986).
In comparison with vertebrate studies our understanding of 
insect neuropeptide inactivation is very limited. The first 
detailed report on the inactivation of an insect neuropeptide was 
provided by Starratt and Steele (1984) who studied the in vivo 
inactivation of the cockroach pentapeptide proctolin (Arg-Tyr-Leu- 
Pro-Thr) by haemolymph. Using [^C-Tyr^Jproctolin they demonstrated 
the degradation of proctolin by an aminopeptidase. Quistad et al. 
(1984) used tritiated proctolin to investigate the degradation of 
the peptide by a number of different tissues. They observed rapid 
proctolin degradation by all the tissues studied. A subsequent 
in vitro study of proctolin degradation by cockroach haemolymph 
indicated different cleavage sites depending on the pH of the 
haemolymph preparation (Steele and Starratt, 1985). Regardless of 
the exact mechanism it seems clear that proctolin is degraded in
the haemolymph. Proctolin is known to be released close to its 
sites of action rather than being a circulating neurohormone 
(O'Shea and Adams, 1986) and a locust neural membrane preparation 
has been shown to contain a proctolin-degrading aminopeptidase 
(Isaac, 1987).
The degradation of AKH/RPCH peptides remains an area of only 
rudimentary understanding. Mordue and Stone (1978) suggested that 
the Malpighian tubules were an important site for AKH-inactivation 
in the locust. The first detailed report on AKH/RPCH degradation 
was provided by Siegert and Mordue (1987) who demonstrated the 
degradation of AKH-I by Malpighian tubules using RP-HPLC to analyse 
the fragments of the degraded peptide. Baumann and Penzlin (1987) 
reported the rapid inactivation of the cockroach peptide, neuro­
hormone D (which is known to be identical to the AKH/RPCH peptide, 
M-I) by intact and homogenized Malpighian tubules. These workers 
suggested that the active uptake of the peptide by tubule cells was 
followed by degradation by intracellular proteases. Isaac (1988) 
has recently characterised a neutral metalloendopeptidase from 
locust neural membranes which degrades AKH-I i_n vitro. Despite 
these findings it is not known where or how AKH/RPCH peptides are 
inactivated in vivo.
I have investigated the degradation of M-AKH by Manduca 
haemolymph in vitro and have obtained a partial characterisation of 
the enzyme involved.
MATERIALS AND METHODS 
Initial Preparation of Haemolymph
Haemolymph was obtained from water-anaesthetised day 4, fifth 
instar larvae by cutting the abdominal horn and collecting the 
haemolymph in polypropylene tubes containing a few crystals of 
phenylthiourea (PTU). The haemolymph from 3-4 larvae was pooled and 
dialysed overnight against 0.1 M Tris/HCl, pH 7.5 (0.01 M Tris/HCl, 
pH 7.2 was used in later experiments). The dialysed haemolymph was 
either diluted in 0.1 M Tris/HCl, pH 7.5 and incubated with peptide
as described below or further purified by ion-exchange 
chromatography.
Partial Purification of the Haemolymph Enzyme
Dialysed haemolymph (4 ml) was loaded onto a DEAE-Sephacel ion 
exchange column (10 x 0.5 cm in a BioRad disposable column) which 
had been equilibrated in 0.01 M Tris/HCl, pH 7.2. The column was 
washed with 0.05 M NaCl in the starting buffer mentioned above at a 
flow rate of 10 ml/h (controlled by an LKB 2132 Microperpex 
peristaltic pump). The enzyme was eluted by a gradient of
0.05-0.275 M NaCl in 50 ml of the starting buffer. The eluate was
monitored at 280 nm by an Isco Model UA-5 absorbance monitor. 
Fractions were collected over 15 min intervals (2.5 ml each) using 
an Isco Model 1200 Pup Golden Retriever fraction collector. A 50 pi 
aliquot from each fraction was assayed for enzyme activity.
Enzyme Incubation
50 Ml of diluted, dialysed haemolymph or partially purified
enzyme was added to a 1.5 ml polypropylene tube containing 1-5 Mg 
of lyophilised M-AKH. For inhibitor experiments the purified enzyme 
was diluted with inhibitor solution and preincubated at room 
temperature for 20-30 min before a 50 pi aliquot of the mixture was 
incubated with lyophilised peptide. For the pH optimization 
experiment partially purified enzyme from the two most active 
fractions was pooled and applied to a series of pasteur pipettes 
containing Sephadex G-25 equilibrated at the appropriate pH by 
0.01 M phosphate buffer (pH 6.0-pH 7.0) or 0.2 M Tris/HCl 
(pH 7.5-pH 9.0). The eluate between 10 and 30 drops which contained 
the enzyme was collected and a 50 \il aliquot of this was incubated 
with 1 Mg of lyophilised peptide.
Incubations were performed at 26°C and usually lasted for 2-3 h 
with the exception of the time-course experiments and inhibitor 
studies (in which the incubation period was extended to 4 h to 
compensate for the dilution of the enzyme). Termination of the 
incubations was achieved by the addition of 1 ml of 0.1% TFA and 
the samples were then stored at -20°C.
HPLC Analysis of Enzyme Activity
Each sample was thawed and loaded onto a primed C SepPak
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cartridge. The sample was washed with 10% acetonitrile (2 ml), 60% 
acetonitrile (2 ml) and 100% acetonitrile (2 ml). The material 
eluted between 1 0 % and 60% acetonitrile was collected in a 
polypropylene tube and freeze-dried. The dried sample was 
resuspended in 1 0  Ml of 1 0 % acetonitrile and injected onto a
Spherisorb C 5 Mm HPLC column (25 x 0.46 cm).
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The solvents used for HPLC were 0.1% TFA (Buffer A) and 0.1%
TFA in acetonitrile (Buffer B). The gradient used for initial 
studies of AKH degradation was 10% B (0-5 min); 10-60% B (5-30 
min); 60% B (30-35 min) and 60-10% B (35-40 min). For the 
determination of the cleavage site the gradient was 15-40% B 
(0-20 min); 40-60% B (20-30 min); 60% B (30-35 min) and 60-15% B 
(35-40 min). The flow rate was 1 ml/min and the eluate was 
monitored at 210 nm. The peaks from the cleavage site experiment 
were collected manually, lyophilised in acid-washed pyrex tubes and 
amino acid analysed as described in Chapter 2.
Separation of Plasma from Cells
The method used for the separation of haemolymph plasma from 
cells was developed by Mead £t al. (1986). Fifth instar larvae 
weighing 2.5-4.0 g were washed with distilled water, blotted dry 
and then chilled on ice. Each larva was swabbed with 70% ethanol 
prior to injection with 1 ml of ice cold anticoagulant solution 
(0.098 M NaOH, 0.146 M NaCl, 0.017 M EDTA and 0.041 M citric acid, 
pH 4.5).The larvae were returned to room temperature for 2 min and 
handled to encourage the even distribution of anticoagulant within 
the animal. Haemolymph was collected, following removal of the 
abdominal horn, in a chilled 1.5 ml polypropylene tube containing 
500 )il of cold anticoagulant. The samples were spun in an MSE 
MicroCentaur at 12,000 g for 3 min. The supernatant (diluted 
plasma) was removed and dialysed overnight against 0.1 M Tris/Hl, 
pH 7.5. The pellet was washed with anticoagulant solution, 
resuspended in 0.1 M Tris/HCl, pH7.5, sonicated for 5 min and then
dialysed overnight. A 50 pi aliquot from each of the pellet and 
supernatant samples was incubated with peptide in order to 
determine the enzyme activity present in the cells and the plasma.
Molecular Weight Estimation
100 pi of dialysed haemolymph was injected onto a Sephacryl 
S-300 gel filtration column equilibrated in 0.1 M sodium phosphate 
buffer, pH 7.5. The sample was eluted at a flow rate of 6  ml/h and 
fractions were collected over 4 min intervals (400 pi each). The 
eluate was monitored at 280 nm. 50 pi aliquots from selected 
fractions were assayed for M-AKH degrading activity. The column was 
calibrated with the following molecular weight standards: Vitamin
(M.Wt. 1,350); cytochrome C (13,000); ribonuclease (13,700); 
haemoglobin (64,500); lactate dehydrogenase (146,000) and 
immunoglobulin G (158,000). The void volume was determined with 
blue dextran.
Effect of Substrate Concentration on Enzyme Activity
The most active fractions from an ion-exchange enzyme 
purification were pooled and used in the preparation of samples 
containing various concentrations of M-AKH. The samples were 
incubated at 26°C for 0, 30, 60 and 120 min, respectively. 
Termination of the incubations was achieved by the addition of 1 ml 
of 0.1% TFA. The samples were then processed through a SepPak 
cartridge and freeze-dried. The dried samples (duplicates for each 
time point)were resuspended in RIA incubation buffer and diluted 
appropriately in the buffer so that a 50 pi aliquot of each sample
contained a quantifiable amount of peptide (in theory). The samples 
were then assayed as described in Chapter 3. The amount of labelled 
peptide displaced in each tube indicated the amount of M-AKH in the 
sample and this figure was used to calculate the initial rate of 
degradation.
Other Sample Preparations
In order to investigate whether the haemolymph M-AKH degrading 
activity was enzymic in nature a sample of dialysed blood was 
divided into two portions. One portion was placed in a boiling 
water bath for 3 min and then cooled and centrifuged. The other 
portion was not boiled but was otherwise treated in the same way.
50 yl aliquots from the boiled supernatant and the unboiled sample 
were removed and assayed.
A preliminary study of the M-AKH degrading activity of whole 
Malpighian tubules was performed. Tubules were excised from a fifth 
instar larva and washed repeatedly in Manduca saline. The tubules 
were then incubated in 1.2 ml of saline at pH 7.0 with 12 yg of 
M-AKH. At appropriate times during the incubation a 200 yl aliquot 
of saline was removed and mixed with 2 0 0  yl of methanol to 
terminate any degradation. The terminated sample was centrifuged at 
14,000 r.p.m. in an Eppendorf 5415 microcentrifuge for 5 min. The 
supernatant was then removed, diluted with 2 ml of 0.1% TFA and 
processed through a SepPak cartridge as described previously. The 
activity of the tubules was compared with that of a sample of 
dialysed haemolymph processed in a similar manner.
RESULTS
M-AKH was shown to be degraded by haemolymph from Manduca 
larvae when analysed by HPLC following the incubation of dialysed
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haemolymph with the peptide at a high concentration (5 x 10 M f 
Fig. 6.1). A comparison of the M-AKH degrading activity of dialysed 
haemolymph with that of intact Malpighian tubules, incubated in 
Manduca saline at pH 7.0, indicated little difference between the 
two tissues in their ability to degrade M-AKH over 30 min. However 
as the incubation period was extended the haemolymph samples 
appeared to be more effective than the intact tubules (Fig. 6.2). 
The time course for the degradation of M-AKH by diluted, dialysed 
haemolymph indicated a half-life for M-AKH of approximately 150 min 
(Fig. 6.3). On this basis the haemolymph M-AKH-degrading activity 
was assessed in subsequent experiments following a 3 or 4 h 
incubation in dialysed haemolymph. The M-AKH degrading activity was 
completely abolished by boiling the haemolymph before the assay 
(Fig. 6.4a). The rate of degradation was also dependent on the 
ambient temperature (Fig. 6.4b), with a of about 2.5. The 
increase in degrading activity with temperature began to fall away 
at temperatures above 30°C. These results suggested that the M-AKH 
degrading activity was probably enzymic in nature, so an attempt 
was made to characterise the M-AKH degrading enzyme(s) from Manduca 
haemolymph.
The enzyme activity was located in the 'plasma' fraction of the 
haemolymph rather than in the cells (Fig. 6.5). Samples of 
haemolymph were collected from insects at various stages of 
development, dialysed and then assayed to determine the levels of
enzyme activity. There appeared to be little variation in the level 
of enzyme activity during development of the insect (Fig. 6 .6 ). 
Although activity in pharate adult haemolymph appeared to be 
slightly greater than in larval haemolymph, the small sample size 
(n = 2) precludes any confidence in this conclusion. Since adult 
haemolymph did not appear to be very much more active than larval 
haemolymph, and since fifth instar larvae possess considerably more 
haemolymph than adult moths, larval haemolymph was used in all 
subsequent experiments.
The molecular weight of the enzyme was estimated by gel
filtration of dialysed, larval haemolymph (Fig. 6.7). The elution
volume (V ) for the M-AKH degrading activity was divided by the
void volume of the column (V ) to obtain a ratio which could beo
compared with the ratios for standards of known molecular weight to 
obtain an estimate of the molecular weight of the enzyme. The 
active component appeared to have a molecular weight of approximately 
6 6  kDa.
Partial purification of the enzyme was achieved by 
DEAE-Sephacel anion exchange chromatography of dialysed larval 
haemolymph (Fig. 6 .8 a). The time-course for M-AKH degradation by 
the most active fraction (Fig. 6 .8 b) indicated a half-life of 
approximately 75 min, closer to the expected half-life of M-AKH 
in vivo (less than 60 min, see Chapter 3). Additional character­
istics of the partially purified enzyme were then investigated. The 
enzyme had a neutral pH optimum (pH 7.0-7.5, Fig. 6.9) notably 
higher than the pH of larval haemolymph (pH 6.7). A number of
inhibitors were assayed for their effect on the M-AKH degrading 
enzyme (Table 6.1). The most effective inhibitors at a 
concentration of 1 mM were the metal-chelating agents EGTA and 
1,10-phenanthroline (87% and 99% inhibition, respectively). The 
sulphydryl inhibitor p-chloromercuribenzoate (PCMB) also appeared 
to be an effective inhibitor at the test concentration. In 
contrast, another sulphydryl inhibitor, N-ethylmaleimide, displayed 
only a weak inhibitory effect. The precise mode of inhibition by 
PCMB therefore remains uncertain. The serine protease inhibitor 
phenylmethanesulphonyl fluoride (PMSF) displayed a limited 
inhibitory effect (2 2 %) on the haemolymph enzyme, however soybean 
trypsin inhibitor (SBTI) had no significant effect and in a 
preliminary experiment the chymotrypsin inhibitor TPCK also failed 
to inhibit the enzyme in dialysed haemolymph (data not shown). None 
of the other inhibitors tested caused a significant reduction in 
the activity of the haemolymph enzyme. A number of other AKH/RPCH 
peptides were incubated with samples of partially purified enzyme 
in order to investigate the specificity of the enzyme (Table 6.2). 
All the peptides tested were degraded to a similar extent during a 
2  h incubation with the enzyme.
In an attempt to determine the primary cleavage site in the
degradation of M-AKH the fragment peaks isolated by RP-HPLC were
collected and analysed for their amino acid composition (Fig.
6.10). The results suggested that the first product peak was the
N-terminal fragment pGlu-Leu-Thr-Phe-Thr. The second product peak 
%
appeared to be composed largely of glycine but its precise identity 
remains uncertain as smaller quantities of threonine, serine,
glutamine and leucine were also present.
The effect of substrate concentration on the rate of M-AKH 
degradation in vitro was determined in a preliminary experiment 
using the M-AKH RIA. The amount of peptide present in each assay 
tube was used to calculate the initial rate of degradation in terms 
of the amount of M-AKH lost during the first hour of incubation. 
Fig. 6.11 shows that the partially purified enzyme was not
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saturated with M-AKH, even at a concentration of 10 M. The rate
of degradation was extremely slow at peptide concentrations below
-7 -510 M. Even if the rate of degradation of 10 M peptide
represents the maximum initial rate, the peptide concentration at
which the rate of degradation is 50% of the maximum rate (known as
“6the Michaelis constant or K ) would be at least 10 M, some fourm
orders of magnitude higher than the concentration of M-AKH in the 
haemolymph of starved larvae reported in Chapter 3.
DISCUSSION
Studies on the inactivation of AKH/RPCH family peptides have 
lagged behind investigations of other aspects of the physiology and 
biochemistry of these peptides. Cheeseman et al. (1976) speculated 
that the half-life of AKH-I in locusts would be around 20 min 
during rest or flight. Preliminary experiments on the degradation 
of AKH-I by locust Malpighian tubules were performed using semi­
isolated tubule preparations (Mordue and Stone, 1978). AKH-I was 
rapidly removed from the bathing fluid and the secreted fluid 
lacked adipokinetic activity. The removal of the peptide from the 
bathing fluid appeared to occur at a constant rate of approximately
2-3 pmol/h regardless of the dose injected. More recently Siegert
and Mordue (1987) investigated the degradation of AKH-I by
homogenates of Malpighian tubules from Schistocerca. The hormone
appeared to be completely destroyed (as defined by the
disappearance of the AKH-I peak from HPLC traces) within 1 h when
incubated with homogenate at 30°C. The breakdown products were
shown to lack adipokinetic activity at a dose of 2 0  pmol/locust and
their structures were determined by gas-phase sequencing. The
primary cleavage appeared to be dependent on the activity of an
6  7endopeptidase at the bond between the [ Pro ] and [ Asn ] or the 
7 8[Asn ] and [Trp ] residues. An aminopeptidase (possibly leucine 
aminopeptidase) and a carboxypeptidase (not carboxypeptidase A) 
were also present in the tubules. The means by which AKH-I entered 
the tubule cells was not determined. A number of other locust 
tissues (but not haemolymph) were also found to be capable of AKH-I 
degradation.
Loughton (1987) confirmed the inability of locust haemolymph to
inactivate AKH-I, however he reported evidence for the involvement
of the fat body in AKH-I inactivation. The fat body plasma membrane
could not degrade AKH-I by proteolysis but Loughton suggested that
protein synthesis was a required step in the inactivation of fat
body membrane-bound AKH-I. Locust synaptic membranes have recently
been shown to possess an endopeptidase capable of degrading AKH-I
4 5by cleavage of the bond between [Asn ] and [ Phe ] (Isaac, 1988). 
This enzyme appears to be similar to the mammalian kidney endo­
peptidase 24.11 (Turner et al., 1985), however it is not known 
whether the locust enzyme has a physiological role in AKH-I
degradation.
The cockroach peptide M-I (also known as neurohormone D) was 
inactivated (as defined by the loss of cardioactivity) iji vitro 
following incubation with intact cockroach Malpighian tubules or 
homogenates of them (Baumann and Penzlin, 1987). The active uptake 
of the peptide into tubule cells was demonstrated and the enzyme 
responsible for peptide inactivation was characterised as a 
metalloendopeptidase with serine or cysteine at the active site. 
These workers found no evidence for inactivation by any other 
tissues from Periplaneta.
Skinner et al. (1987) investigated the degradation of tritiated 
M-II (also known as CC-2) by haemolymph and homogenates of fat body 
and Malpighian tubule from Periplaneta. They found the half-life of 
the peptide to be around 1 h in vitro and iri vivo, with very little 
degradation by haemolymph. It was suggested that the synthesis and 
secretion of M-II were more important than degradation in 
determining the circulating levels of the peptide.
My preliminary HPLC analyses indicated that haemolymph from 
larval Manduca was capable of degrading the native peptide, M-AKH 
in vitro. In contrast with previous work in other insects, peptide 
degradation by haemolymph appeared to be as effective as that 
observed following the incubation of peptide with intact Malpighian 
tubules. Experiments with boiled haemolymph and incubations at 
different ambient temperatures suggested that the degrading 
activity was probably due to a proteolytic enzyme. The 
characteristics of the enzyme were investigated using dialysed and 
partially purified haemolymph preparations. An assay of the
separated ’plasma' and 'cellular' fractions of the haemolymph 
indicated that the enzyme was a soluble protease rather than a 
membrane-bound or intracellular enzyme.
Ziegler (1984) reported developmental variation in the 
responsiveness of the Manduca fat body to i n  vivo injections of CC 
extract. He concluded that the variation was due to changes in the 
fat body rather than changes in the level of hormone synthesis or 
secretion. My results suggest that the variation in response is 
unlikely to be due to changes in the level of M-AKH degradation by 
haemolymph as the level of enzyme activity did not vary 
significantly during the late fourth and fifth larval instars and 
into adulthood.
The time course for the breakdown of M-AKH by the partially 
purified enzyme indicated a half-life of around 75 min for the 
hormone under the assay conditions. The half-life of M-AKH in 
starved Manduca larvae appeared to be around 60 min (as described 
in Chapter 3) so that the time-course data are consistent with a 
possible role for the haemolymph enzyme in M-AKH degradation. 
However the pH optimum experiment indicated that the enzyme would 
not be maximally active at the pH of larval haemolymph.
The haemolymph enzyme appeared to be similar, in terms of its 
molecular weight ( 6 6  kDa), pH optimum (7.0-7.5) and inhibition by 
metal-chelating agents, to a soluble metalloendopeptidase isolated 
from rat brain by Orlowski et al. (1983). These workers defined the 
amino acid requirements for a suitable peptide substrate. The 
peptide should have aromatic residues at positions P'^ and or 
P'3 , P^ and P^ (where P^ is the residue adjacent to the cleaved
bond on the N-terminal side, is next to on the N-terminal
side and P'^ is three residues away from the cleaved bond on the
C-terminal side). Amino acid analysis of the fragments produced by
enzymatic cleavage of M-AKH suggests that one of the primary
products may be the pentapeptide pGlu-Leu-Thr-Phe-Thr. Cleavage at
5 6the bond between the [ Thr ] and [Ser ] residues implies partial
fulfilment of the substrate requirements defined by Orlowski et al.
The P^ and P'^ positions are occupied by the aromatic residues 
4 8[Phe ] and [Trp ] , respectively, but the P^ position is occupied by
[Thr ] which is not an aromatic amino acid. All the AKH/RPCH
4 8peptides sequenced to date posess a [ Phe ] and a [ Trp ] residue and 
all the peptides assayed with partially purified enzyme were 
degraded as effectively as M-AKH. However the fragments produced by 
the cleavage of non-M-AKH peptides have not been analysed so it 
would be premature to conclude that the peptides which were assayed 
were all cleaved in the same manner by a single enzyme.
Although the haemolymph may not be the only tissue containing 
M-AKH degrading activity, it is clear that Manduca differs from 
locusts and cockroaches in which the haemolymph has virtually no 
activity in this regard. The difference between these insects may 
be related to the rate of circulation of the haemolymph which is 
very slow in the caterpillar compared with that of the locust or 
the cockroach.
In order to evaluate the probable importance of the haemolymph 
enzyme an attempt was made to estimate the concentration of M-AKH 
at which enzyme activity was limited by lack of substrate. The data 
suggest that the K^ of the enzyme may be at least four orders of
magnitude higher than the concentration of M-AKH in the haemolymph 
of starved larvae. At best this would appear to suggest that the 
M-AKH degrading enzyme in Manduca larval haemolymph represents a 
low-affinity inactivation system rather than the principal means of 
peptide inactivation. However the haemolymph enzyme may not 
normally operate under equilibrium conditions and it is likely that 
additional haemolymph enzymes remove the products of the initial 
M-AKH cleavage increasing the effectiveness of the M-AKH cleaving 
enzyme. The pattern of RP-HPLC peaks from peptide samples incubated 
with partially purified enzyme was much simpler than that obtained 
from samples incubated with dialysed haemolymph, suggesting the 
presence of additional enzymes that further cleave the hormone 
fragments.
In conclusion, a neutral metalloendopeptidase has been 
identified in the haemolymph of larval Manduca. The enzyme appears 
to be similar to a soluble peptidase previously characterised from 
rat brain. The physiological role of this enzyme remains unclear.
Fig. 6.1. HPLC analysis of M-AKH degradation by dialysed larval
haemolymph. Haemolymph from day 4, fifth instar larvae
was dialysed against 0.2 M Tris/HCl, pH 7.5 and then
diluted to 20% haemolymph. 50 ul aliquots of diluted
haemolymph were incubated with lyophilised M-AKH (5 yg)
for 0 h or 4 h. Incubations were terminated with 1 ml of
0.1% TFA sind the mixture was SepPaked prior to HPLC on a
Spherisorb 5 ym C column (25 cm x 0.46 cm). Solvent A lo
was 0.1% TFA; solvent B was 0.1% TFA in acetonitrile. 
Gradient elution is indicated by the dotted line. Flow 




























Fig. 6.2. In vitro degradation of M-AKH by intact Malpighian
tubules (O) or dialysed haemolymph (#). Tubules from 
one insect (day 4, fifth instar larva) were incubated 
with 12 yg of M-AKH in 1.2 ml of Manduca saline, pH 7.0. 
200 yl aliquots were removed at the times indicated and 
terminated with 200 yl of methanol. The terminated 
sample was centrifuged at 14,000 r.p.m. for 5 min, the 
supernatant removed, diluted with 0.1% TFA, and SepPaked 
prior to HPLC. 1.2 ml of dialysed haemolymph was also 
incubated with 12 yg of M-AKH and aliquots taken as 
above. HPLC analysis as described in Fig. 6.1. Each 
point represents the mean of duplicate samples, with the 
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Fig. 6.3. Time course for the degradation of M-AKH by diluted,
dialysed haemolymph. Degradation was assessed in terms 
of the change in the M-AKH peak height. Each point 
represents the mean of duplicate samples. Details of 
incubation and analysis as in Fig. 6.1.
Fig. 6.4. a) Comparison of M-AKH degradation by boiled and
unboiled haemolymph from day 4 fifth instar larvae. 
Details as for Fig. 6.1. Results are the means of 
duplicate samples.
b) Effect of temperature on M-AKH degradation by
dialysed haemolymph. Incubations were for 4 h at the 
temperatures indicated with other details the same as 
in Fig. 6.1. All points represent the means of 
triplicate samples. Rate of degradation was 
calculated from the peak height for M-AKH having 
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Fig. 6.5. Localisation of the M-AKH degrading enzyme in larval 
haemolymph. Plasma and cells were separated by the 
method of Mead et al. (1986). Results represent the 























Fig. 6.6. Developmental variation in the levels of M-AKH degrading 
enzyme in Manduca haemolymph. Developmental stages 
indicated are fourth larval instar (IVL), fifth larval 
instar (VL), wandering phase (W), pharate pupa (PP), 
pupa (P), pharate adult (PA) and adult (A). Each point 
represents the mean of duplicate samples. Enzyme 
activity is expressed in terms of the percentage 
degradation of M-AKH after 1 h (Q) or 3 h (#) 
incubations.
Fig. 6.7. Molecular weight determination for the M-AKH degrading 
enzyme. 100 ul of dialysed haemolymph was loaded onto a 
Sephacryl S-300 gel filtration column and eluted with 
phosphate buffered saline, pH 7.5. The column was 
calibrated with vitamin (1,350); cytochrome c
(13.000); ribonuclease (13,700); haemoglobin (64,500); 
lactate dehydrogenase (146,000) and immunoglobulin G
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Fig. 6.8. a) Partial purification of the haemolymph enzyme by
DEAE-Sephacel ion exchange chromatography. 4 ml of 
dialysed haemolymph was loaded onto the column in 
0.01 M Tris/HCl, pH 7.2 containing 0.05 M NaCl. The 
column was washed in this buffer and then eluted by a 
gradient of 0.05-0.275 M NaCl in the Tris buffer at a 
flow rate of 10 ml/h. Dotted line indicates enzyme 
activity of fractions around the final absorbance 
peak (no activity observed in earlier peaks). Each 
point represents the mean of duplicate samples. Each 
fraction was collected over a 15 min period (2.5 ml).
b) Time course for degradation of M-AKH by partially 
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Fig. 6.9. Determination of the pH optimum for activity in the 
partially purified enzyme preparation. Samples of 
purified enzyme were buffer-exchanged using small 
columns containing Sephadex G-25 equilibrated at the 
appropriate pH. Each point and bar represents the 
mean ± S.E. for 4 samples.
Table 6.1. Effect of protease inhibitors on the activity of the
partially purified enzyme.
Inhibitor Concentration %  Inhibition
Phosphoramidon 0.46 x 10"3 M 0
S.B.T.I. 0.5 mg/ml 2
Leupeptin 0.5 x 10“3 M 3
Bestatin 1.45 x 10"3 M 4
N-Ethylmaleimide 1.0 x 10-3 M 13
PMSF 1.0 x 10~3 M 22
PCMB 1.0 x 10"3 M 70
EGTA 1.0 x 10~3 M 87
1,10-Phenanthroline 1.0 x 10'3 M 99
Enzyme and inhibitor were preincubated for 20 min and then added to 
lyophilised M-AKH and incubated for 4 h at 26°C. Results are 
expressed in terms of the % inhibition compared with control 
samples in which the enzyme was preincubated with buffer only.
Table 6.2. Investigation of the substrate specificity of the
partially purified haemolymph enzyme.








50 pi of enzyme was incubated with 1 yg of each peptide for 3 h at 
26°C. Termination and HPLC analysis were performed as described in 
Fig. 6.1. Each value represents the mean of duplicate samples.
Fig. 6.10. Analysis of the primary cleavage site in the hydrolysis 
of M-AKH by partially purified enzyme. 40 yg of M-AKH 
was incubated for 2 h with 500 y 1 of enzyme. Aliquots 
from the reaction mixture were analysed by HPLC 
following termination and SepPak processing. Three peaks 
were collected, pooled and lyophilised. Chromatography 
details as in Fig. 6.1 with the gradient used indicated 
by the dotted line. Lyophilised material from the HPLC 
analysis was hydrolysed in 6 N HC1 for 24 h in vacuo and 
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Fig. 6.11. Effect of substrate concentration on the activity of the 
M-AKH degrading enzyme. Partially purified enzyme was 
incubated with various concentrations of peptide. The 
amount of peptide degraded during the first hour was 
calculated from the RIA determination of the amount of 
peptide remaining. The rate of degradation during the 
first hour is shown. Each point is the mean of duplicate 
samples.
CHAPTER 7. METABOLIC REGULATION IN MANDUCA SEXTA
INTRODUCTION
Our current understanding of the changes which occur in 
carbohydrate and lipid metabolism during the late larval and adult 
development of Manduca sexta and of the factors which regulate 
these changes, is principally due to the work of Rolf Ziegler, Karl 
Siegert and their co-workers. The work reported in this thesis 
provides additional information on the physiology and pharmacology 
of the peptide hormone M-AKH which acts as a metabolic regulator in 
Manduca.
LARVAL METABOLISM AND ITS HORMONAL REGULATION IN MANDUCA
Caterpillar metabolism is primarily anabolic with the ingestion 
of food permitting growth and the accumulation of energy reserves 
for subsequent developmental stages (pupa and adult), which depend 
largely (in the case of the adult) or entirely (in the case of the 
pupa) on reserves of energy accumulated during the larval stage. 
However Manduca larvae do not feed continuously (Reinecke et al., 
1980) and physiological starvation occurs during the last larval 
moult (for approximately 24 h) and from the onset of the wandering 
phase of the fifth and final larval instar until adult eclosion 
(approximately 25 days later). Additional periods of starvation may 
be encountered if the food resource becomes scarce and the 
caterpillar has to actively search for new food (Ziegler, 1985).
During the fifth larval 1stadium the amount of lipid and 
carbohydrate stored in the fat body increases from 5 to 180 mg of
triacylglycerol and from 1 to 100 mg of glycogen (Siegert, 1987a). 
Lipid accumulation is thought to predominate during the first two 
days of the Istadium with glycogen accumulation occurring during days 
3 and 4 (Ziegler and Roth, 1985). Larval haemolymph acts as an 
additional store of carbohydrate as well as a transporting medium, 
but the haemolymph lipid levels remain low (2 mg/ml) until the 
wandering phase when they increase to 8-10 mg/ml (Ziegler, 1985). 
The reason for this increase is not known but it may indicate the 
release of lipid from the fat body to fuel wandering activity. 
Trehalose is the major transported carbohydrate in Manduca and its 
concentration in larval haemolymph is regulated mainly by its 
synthesis from glucose in the fat body.
The Larval Response to Starvation
The metabolic response to starvation may take the form of an 
overall reduction in the rate of metabolism and/or the mobilization 
of stored fuels to permit continued activity. Manduca larvae on day 
3 of the fifth instar will reduce their respiration rate by 65-70% 
within 20 h of the onset of experimental starvation. A similar 
decrease has been reported during the final larval moult and at the 
wandering phase (Siegert and Ziegler, 1982). With the exception of 
the small increase in haemolymph lipid levels at wandering, lipid 
levels do not change in starved larvae (Ziegler, 1985), but stored 
carbohydrate is mobilized in response to starvation. The overall 
change in haemolymph carbohydrate level following the onset of 
starvation may be quite small and Ziegler (1979) showed that an 
assay of fat body glycogen phosphorylase activity provided a more
sensitive measure of changes in carbohydrate metabolism. In feeding 
Manduca larvae around 10% of the fat body phosphorylase is in the 
active form (phosphorylase a) with the remainder in the inactive 
form (phosphorylase b). During experimental starvation of day 3 
fifth instar larvae the proportion of phosphorylase a increases to 
30-50% of the total within 3 h of the onset of starvation. The 
resultant glucose is converted to trehalose, hence the fall in 
haemolymph glucose levels even after phosphorylase activation. 
During developmental starvation glucose liberated by the activation 
of fat body phosphorylase is used as a substrate for chitin 
synthesis (Siegert, 1987b).
The activation of phosphorylase is not simply a response to the 
cessation of feeding activity. Larvae fed on an agar diet showed 
phosphorylase activation, although feeding movements continued, as 
they were unable to obtain any nutrient from the diet (Siegert and 
Ziegler, 1983). The haemolymph trehalose level does not decrease at 
the onset of starvation and it would therefore seem unlikely that a 
change in trehalose level acts as the signal for phosphorylase 
activation. The decrease in haemolymph glucose at the onset of 
starvation (from 250 Mg/ml to less than 100 yg/ml in 3 h) parallels 
the increase in phosphorylase activity (Siegert, 1987b). Injection 
of an amount of glucose less than that normally ingested within 3 
h, prevented phosphorylase activation in starving larvae whereas 
injection of trehalose had no such effect. It appeared that a fall 
in the level of haemolymph glucose may act as a signal for 
phosphorylase activation. However, phosphorylase activation was 
not observed when larvae were fed on an agar diet containing 3.2%
sucrose or glucose or fructose or trehalose. In the case of the 
fructose-fed larvae the haemolymph glucose concentration was 
similar to that of starved or agar-fed larvae yet the proportion of 
active phosphorylase remained low. The signal for phosphorylase 
activation therefore remains unclear (Siegert, 1988).
M-AKH and Larval Starvation
The corpora cardiaca of adult and larval Manduca contain a 
factor which causes phosphorylase activation when injected into day 
3 fifth instar larvae (Ziegler, 1979; Ziegler et al., 1988), but 
has no effect on larval haemolymph lipid levels (Ziegler, 1984). 
When the CC were removed from such larvae fat body (phosphorylase 
was not activated in response to experimental starvation. It was 
concluded that the larval CC contain a factor, referred to as the 
glycogen phosphorylase activating hormone (GPAH), which regulates 
larval carbohydrate metabolism in response to starvation (Siegert 
and Ziegler, 1983). GPAH is produced by the intrinsic 
neurosecretory cells of the larval CC (Ziegler et al., 1988). 
Preliminary HPLC analysis suggested that the larval GPAH may be 
different to the adipokinetic hormone (M-AKH) from adult CC 
(Ziegler et al., 1986), however recent evidence from amino acid 
analysis and molecular weight determination suggested that GPAH was 
identical to M-AKH (Ziegler et al., 1987). My work has shown that 
larval Manduca CC on day 3 of the fifth instar contain 2 pmol of 
M-AKH (as defined by radioimmunoassay) and this figure has been 
used to compare the activity of larval CC extracts reported by 
Ziegler et al. (1988) with the data reported here for phosphorylase
activation by synthetic M-AKH. The correspondence of the data 
indicates the likely identity of GPAH with the nonapeptide M-AKH. 
Ziegler et al. (1988) reported that the GPAH was located 
exclusively within the CC. Although I found a small amount of M-AKH 
immunoreactive material in the larval brain and nerve cord this 
material did not co-elute with M-AKH when analysed by HPLC. It 
seems unlikely therefore that the material in the brain and nerve 
cord is M-AKH/GPAH, whereas the CC material was confirmed as 
M-AKH/GPAH by its co-elution with synthetic M-AKH.
The titre of M-AKH immunoreactive material in the larval 
haemolymph has been shown to be elevated within 1 h of the onset of 
experimental starvation (see Chapter 3). Assuming that the majority 
of this material is M-AKH I have obtained the first direct evidence 
for the release of M-AKH/GPAH in response to larval starvation. The 
level of active phosphorylase has been shown to return to the 
resting level within 24-48 h of starvation despite the continued 
absence of food (Siegert, 1987b). Phosphorylase inactivation may be 
due to a reduction in the secretion of GPAH, combined with the 
inactivation of the hormone, probably by the action of proteolytic 
enzymes or due to a change in the responsiveness of the fat body 
despite the continued presence of GPAH. Siegert (1988) injected 
24 h and 48 h-starved larvae with CC extract and observed the 
persistent responsiveness of the fat body. My results also support 
the former explanation for phosphorylase inactivation as the M-AKH 
titre declined to the resting level within 3 h of the onset of 
starvation. It is not known whether a reduction in secretion or
increased degradation is more important in reducing the M-AKH/GPAH 
titre. A neutral metalloendopeptidase capable of degrading M-AKH 
has been partially purified from larval haemolymph (see Chapter 6). 
The i n  vivo function of this enzyme is not known but it seems 
unlikely that it has a primary role in M-AKH/GPAH inactivation.
Ziegler (1985) has explained the transient nature of the larval 
response to starvation in terms of a trade-off between growth and 
development to a subsequent stage. Manduca larvae may attain a 
weight of 10 g by the end of the fifth btadium, however they can 
pupate successfully and emerge as small adults once they have 
reached a weight of 4 g (Nijhout, 1975). Consequently a larva 
weighing 4 g or more when deprived of food will begin to search for 
food whilst mobilizing stored carbohydrate to fuel this process. If 
food is not found within a day it will be more energetically 
efficient for the larva to become quiescent and then pupate to 
become a moth of reduced size rather than to continue the search 
for food in an attempt to attain the maximum weight. Hence the 
inactivation of fat body phosphorylase despite the continuation of 
starvation. By contrast larvae that are starved early on in the 
fifth Istadium (when they are less than 4 g in weight), will continue 
to search for food until it is found (they may then moult to a 
supernumerary larval instar) or until they die (such larvae are too 
small to pupate successfully).
ADULT METABOLISM AND ITS HORMONAL REGULATION IN MANDUCA
The metabolism of the adult moth is primarily catabolic 
although some synthesis of fuel stores may occur following feeding.
Adult development is not significantly affected by starvation 
following eclosion and female moths are autogenous, that is they 
can reproduce despite starvation as adults. The number of eggs laid 
by a starved female will be greatly reduced compared with the 
number laid by a fed female (100-200 cf. approximately 1,000 eggs).
The Adult Response to Starvation
In contrast with the larval response, adult fat body glycogen 
phosphorylase is activated over a period of days rather than hours 
in response to starvation and there is no evidence of phosphorylase 
inactivation as starvation continues. Hjaemolymph glucose levels are 
very low in adult Manduca and show no correlation with the 
nutritional state of the moth or the proportion of active 
phosphorylase. There is a negative correlation between total 
haemolymph carbohydrate content and the level of active 
phosphorylase. Since trehalose is the major haemolymph carbohydrate 
a decrease in haemolymph trehalose may signal the need for
phosphorylase activation during adult starvation (Ziegler, 1985).
Although CC extract can activate adult fat body phosphorylase 
(Ziegler, 1984), cardiacectomy does not prevent phosphorylase 
activation during adult starvation. It would appear that M-AKH/GPAH 
does not control adult carbohydrate metabolism during starvation. 
Similarly the increased level of haemolymph lipids in starved moths 
is not due to the action of M-AKH/GPAH (Ziegler, 1985).
Unlike larvae, moths can afford to mobilize all their reserves
of energy during starvation. This may explain the difference 
between the adult and larval response to starvation. In the larva
changes in one or more haemolymph carbohydrate rapidly signals the 
onset of starvation leading to a quick response, mediated by GPAH, 
which lasts for approximately 24 h. In the moth, phosphorylase 
activation seems to depend upon a decrease in the total level of 
energy substrate. The adult response is slow (several days) and 
will last for as long as starvation continues.
Flight Metabolism in Manduca
Carbohydrate metabolism appears to be important during pre­
flight warm-up, particularly at low ambient temperatures (Joos, 
1987) and at the initiation of flight by Manduca (Ziegler and 
Schulz, 1986b). During pre-flight warm-up the circulation between 
the abdomen and the thorax may be restricted so thoracic fuel 
stores must be utilized. Flight muscle glycogen is degraded during 
the initial phases of pre-flight warm-up to provide the three- and 
four-carbon compounds which are required to prime the TCA cycle 
(Sacktor, 1975).
A sharp decline in the level of haemolymph trehalose has been 
reported during the first 5 min of tethered flight (Ziegler and 
Schulz, 1986b). After 5 min the haemolymph trehalose level 
stabilized due to a reduced rate of utilization (11% of the initial 
rate). Active fat body glycogen phosphorylase cannot supply the 
sugar required during early flight at more than 25% of the rate at 
which it is utilized. It was concluded that the haemolymph pool is 
the source of most of the carbohydrate used during early flight.
The fat body supplies carbohydrate at a reduced rate during 
sustained flight. Oxygen consumption is very high during the first
2 min of flight (Heinrich, 1971) and carbohydrate thus provides 
additional energy when it is most needed.
The CC do not regulate carbohydrate metabolism during flight.
As with starved moths, phosphorylase activation appears to depend 
upon a fall in the haemolymph trehalose level, which occurs during 
the first 5 min of flight (Ziegler and Schulz, 1986b). M-AKH does 
not therefore appear to be important for the regulation of adult 
carbohydrate metabolism during starvation or flight.
A comparison of oxygen consumption during flight with changes 
in haemolymph lipid levels suggests that lipid is the primary fuel 
for flight in Manduca (Heinrich, 1971; Ziegler and Schulz, 1986a). 
Haemolymph lipid levels decrease as lipid is utilized during the 
early stages of flight. After 30 min the rate of lipid mobilization 
from the fat body equals the rate of utilization by the flight 
muscles and the level of haemolymph lipid stabilizes (Ziegler and 
Schulz, 1986a). Even at the minimal value the haemolymph lipid 
level in adult Manduca is equivalent to the maximum level reported 
in locusts during flight (Goldsworthy and Cheeseman, 1978).
Cardiacectomized moths rarely fly for longer than 30 min and 
they do not display the changes in haemolymph lipid levels 
described above. Ziegler and Schulz (1986a) concluded that lipid 
mobilization during flight in Manduca was controlled by the 
nonapeptide hormone, M-AKH from the CC. Radioimmunoassay and HPLC 
analysis suggest that M-AKH is located exclusively with the CC 
(approximately 20 pmol/CC, Chapter 3). As with the larval tissue
extracts, RIA analysis of HPLC isolated fractions suggests that the 
imrcunoreactive material observed in the adult brain is not M-AKH. 
The identity of the brain M-AKH-immunoreactive material is not 
known.
I have compared the adipokinetic activity of synthetic M-AKH in 
resting moths with that of a CC extract (see Chapter 4). Both 
agonists produced the same maximum increase in haemolymph lipids 
(about 30 mg/ml), however the CC extract appeared to be slightly 
more potent than synthetic M-AKH at low doses. As I obtained only a 
partial dose-response curve for the CC extract the significance of 
the difference between the two curves remains uncertain. The 
difference may be an artefact due to inaccuracies in the 
preparation of synthetic M-AKH at low doses. This would appear to 
be the most economical explanation for the data and it would 
confirm the role of M-AKH as the only adipokinetic hormone in 
Manduca CC.
However several insect species have been shown to possess two 
AKH/RPCH peptides. The corn earworm moth, Heliothis zea possesses a 
nonapeptide identical to M-AKH (Jaffe et al., 1986) and a second 
AKH/RCH peptide has recently been sequenced from this species 
(Jaffe et al., 1988b). The difference between the adipokinetic 
activity of M-AKH and that of CC extract may be due to an 
additional adipokinetic factor in the CC. A small amount of 
M-AKH-immunoreactive material was observed in pooled fractions 
eluting later than M-AKH from a reversed-phase HPLC column. It is
not known whether this material has any adipokinetic activity in 
Manduca, but it seems unlikely that it represents a second AKH/RPCH 
peptide in Manduca.
I have investigated the pharmacology of the adipokinetic 
response in Manduca using synthetic AKH/RPCH family peptides. Only 
M-AKH was a full agonist but HTF-II, AKH-I and M-II were partial 
agonists. The serine residues at positions 6 and 7 in M-AKH appear 
to be essential for full biological activity. A competition assay 
in which AKH/RPCH peptides were co-injected in ten-fold excess with 
M-AKH, suggested that M-AKH and the partial agonists bind to the 
same population of receptors in adult Manduca fat body.
CHAPTER 8. THE POTENTIAL COMMERCIAL APPLICATION OF
ADIPOKINETIC HORMONES
THE DEVELOPMENT OF NOVEL INSECTICIDES
The application of insect hormones as novel insecticides was 
first proposed some thirty years ago, long before the 
identification of the adipokinetic hormone family (Williams, 1956). 
At that time studies on the hormones controlling insect metamor­
phosis had begun to suggest that juvenile hormone (JH) might be 
developed as an insect-specific pesticide. With the growing concern 
that insecticides should be arthropod-specific with minimal 
environmental impact, interest in the development of JH-based 
insecticides and other methods of biological control increased. The 
discovery of insect adipokinetic hormones provides another 
potential source of insect-specific pesticides.
As with the JH-based insecticides, the effect of an AKH-based 
insecticide would probably be less rapid than conventional 
neurotoxic insecticides in disabling the target insect. The 
disruption of flight metabolism by an AKH-based insecticide could 
be a useful means of controlling locust swarms. A treated locust 
may not be able to sustain flight for as long as a normal locust 
and flight speed has been shown to be greatly reduced following CC 
removal (Goldsworthy and Coupland, 1974).
Manduca is a relatively minor agricultural pest in the United 
States but Heliothis, which possesses an identical adipokinetic 
hormone is a major pest of several crops.For lepidopteran pests an 
AKH-based insecticide might be targeted against the larval stage so
as to disrupt the regulation of carbohydrate metabolism, 
particularly at the larval-larval moult, when there is a massive 
flux of carbohydrate through the insect as a result of the 
digestion of chitin from the old cuticle and the release of 
carbohydrate from the fat body to act as a substrate for the 
synthesis of the new cuticle (Siegert, 1987b). The metabolic 
disturbance caused by an AKH-based insecticide would ideally 
prevent the larva from moulting successfully and eventually kill 
it, thus reducing significantly the damage to the host plant caused 
by the later larval instars.
Unfortunately there are no reports to date on the effects of 
excessively high or low levels of AKH on insect survival. However a 
number of studies have investigated the effects of conventional 
insecticides on AKH activity. A variety of insecticides were shown 
to cause the abnormally high release of AKH from the locust CC at 
the paralytic stage of poisoning. It was suggested that the 
metabolic disturbance and behavioural changes produced by the 
abnormal release of AKH may contribute to the lethal effect of 
these insecticides (Samaranayaka, 1974). This study did not 
indicate whether the insecticides were acting directly on the CC or 
indirectly through the hyperstimulation of the central nervous 
system (CNS). More recently a number of conventional insecticides 
(organochlorines, organophosphates and pyrethroids) have been shown 
to act directly on the locust CC causing the release of AKH prior 
to any other poisoning symptoms (Singh and Orchard, 1982, 1983).
The CC may be more sensitive to insecticide treatment than the CNS 
because they are not surrounded by the perineurium but are directly
exposed to any insecticide in the haemolymph (Singh and Orchard,
1982).
It would be naive to imagine that a solution of an AKH peptide 
could simply be sprayed over a field containing the target insect in 
order to control it successfully. Peptides are not stable in an 
agricultural environment and the problem of penetration into the 
insect is considerable. Quistad et al. (1984) reported insignificant 
penetration of the cuticle of Manduca larvae by topically applied 
tritiated proctolin. When Manduca larvae were fed on artificial diet 
containing tritiated proctolin only 5% of the intact peptide was 
recovered after 2-5 h whilst substantial quantities of tritiated 
metabolites were identified. Studies on the locust and the cockroach, 
as well as the data for Manduca reported here (Chapter 6) suggest 
that AKH/RPCH family peptides are also susceptible to enzymatic 
degradation.
A number of alternative strategies for disrupting AKH-regulated 
metabolism may be suggested (Keeley and Hayes, 1987). The problems 
of penetration may be overcome by the development of non-peptidic 
analogues which may act as AKH agonists or antagonists while 
resisting enzymatic degradation. Structure-activity studies such as 
those described in Chapter 5 will be of assistance in the 
development of suitable analogues. Alternatively agents which mimic 
or antagonise the effects of AKH-releasing agents may be developed. 
The formamidine insecticide chlordimeform, which is an octopamine 
agonist, stimulates AKH release in locusts, presumably by binding to 
octopamine receptors on the CC (Singh et al., 1981). Another possible 
target would be the system responsible for AKH inactivation. The
haemolymph peptidase described in Chapter 6 may be a part of this 
system. The disruption of enzyme activity could be a means whereby 
hormone levels are either artificially increased or reduced.
Perhaps the most interesting possibility is the use of genetic 
manipulation in the development on an AKH-based insecticide. Once 
the gene for an AKH/RPCH peptide is identified and sequenced it 
could be inserted into an insect-specific virus. A solution 
containing the transformed virus could then be sprayed over the 
host plant. As the target insect feeds on the host plant it should 
ingest the virus which can then infect the insect's cells. It has 
been shown that insect cells infected with a virus containing the 
gene for human alpha-interferon can express the gene and release 
interferon into the haemolymph (Maeda et al., 1985). Perhaps this 
method offers the best possibility for delivering effective 
quantities of an AKH-based insecticide to the target insect.
Realistically there must be some doubt as to whether the 
disruption caused by an AKH insecticide would be sufficiently 
debilitating to make it a commercially viable insecticide. I have 
therefore indulged in some rather fanciful 'research' into other 
applications for adipokinetic hormones.
FURTHER APPLICATIONS FOR ADIPOKINETIC HORMONESt
The existence of eccentric entrepreneurs peddling a variety of 
dubious medicinal treatments has been a feature of many films based 
in the 'Wild West' of America during the nineteenth century. I was 
therefore intrigued to discover probably the earliest reference to 
the pharmaceutical application of adipokinetic hormones in a copy
+ The information in this section is entirely fictitious.
of the 'Tucfson Post1 which I obtained recently from an anonymous 
source (Fig. 8.1). It is not known whether this preparation had 
the desired effect on Prof. Ziegler's 'patients'.
More recently a German pharmaceutical company has been 
marketing a similar product aimed at the health-conscious, 
marathon-running citizen of the 1980s (Fig. 8.2). I have not been 
able to contact the manufacturers in order to question them about 
the precise composition of this product.
Finally, I recently discovered a company of heating engineers 
who have adopted the name of the adipokinetic hormone family, no 
doubt because of their interest in improving the energy supply to 
their clients (Fig. 8.3.). This just goes to show that you truly 
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Fig. 8.2. An advertisement from 'Sports Medicine Monthly', 
September, 1988.
Fig. 8.3. Adipokinetic hormones on the streets of 
Trowbridge!
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